Toby Maher, MD, PhD

Title(s)Professor of Clinical Medicine
SchoolKeck School of Medicine of Usc
AddressIRD 720 2020 Zonal Avenue
Health Sciences Campus
los angeles CA 90033
ORCID ORCID Icon0000-0001-7192-9149 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Southampton Medical School, UKBM1998Medicine
    Royal College of Physicians, London, UKFRCP2002Internal Medicine
    Imperial College London, LondonMSc2004Respiratory Medicine
    University College London, LondonPhD2009Medicine

    Collapse Overview 

    Collapse Featured Content 
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Efficacy and Safety of Admilparant, an LPA1 Antagonist in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial. Am J Respir Crit Care Med. 2024 Oct 11. Corte TJ, Behr J, Cottin V, Glassberg MK, Kreuter M, Martinez FJ, Ogura T, Suda T, Wijsenbeek M, Berkowitz E, Elpers B, Kim S, Watanabe H, Fischer A, Maher TM. PMID: 39393084.
      View in: PubMed   Mentions:    Fields:    
    2. Pioneering Research Driving Progress toward a Cure for Interstitial Lung Disease (ILD): Introduction to the AJRCCM Special Issue on ILD (Part 2). Am J Respir Crit Care Med. 2024 Aug 15; 210(4):373-374. Podolanczuk AJ, Maher TM, Drake WP, Sime PJ, Eickelberg O, DeMeo DL, Richeldi L. PMID: 39145623; PMCID: PMC11351802.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):435-443. Mattos WLLD, Khalil N, Spencer LG, Bonella F, Folz RJ, Rolf JD, Mogulkoc N, Lancaster LH, Jenkins RG, Lynch DA, Noble PW, Maher TM, Cottin V, Senger S, Horan GS, Greenberg S, Popmihajlov Z. PMID: 38484130.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    4. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):401-423. Adegunsoye A, Kropski JA, Behr J, Blackwell TS, Corte TJ, Cottin V, Glanville AR, Glassberg MK, Griese M, Hunninghake GM, Johannson KA, Keane MP, Kim JS, Kolb M, Maher TM, Oldham JM, Podolanczuk AJ, Rosas IO, Martinez FJ, Noth I, Schwartz DA. PMID: 38573068; PMCID: PMC11351799.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):508-511. Whalen W, Berger K, Kim JS, Simmons W, Ma SF, Kaner RJ, Martinez FJ, Anstrom KJ, Parfrey H, Maher TM, Hammond M, Clark AB, Thickett D, Jenkins RG, Wilson AM, Noth I. PMID: 38762791; PMCID: PMC11351790.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):521-523. Calamita E, Liu WH, Ogger PP, Griffin L, Michalaki C, Murphy F, Worrell J, McCarthy C, Agro A, Hertz M, Maher TM, Lloyd CM, Molyneaux P, Kumar V, Byrne AJ. PMID: 38935441.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    7. Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):444-454. Huang Y, Ma SF, Oldham JM, Adegunsoye A, Zhu D, Murray S, Kim JS, Bonham C, Strickland E, Linderholm AL, Lee CT, Paul T, Mannem H, Maher TM, Molyneaux PL, Strek ME, Martinez FJ, Noth I. PMID: 38422478; PMCID: PMC11351805.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    8. Deep Learning-based Segmentation of Computed Tomography Scans Predicts Disease Progression and Mortality in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):465-472. Thillai M, Oldham JM, Ruggiero A, Kanavati F, McLellan T, Saini G, Johnson SR, Ble FX, Azim A, Ostridge K, Platt A, Belvisi M, Maher TM, Molyneaux PL. PMID: 38452227; PMCID: PMC11351794.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. A comparison of respiratory oscillometry and spirometry in idiopathic pulmonary fibrosis: performance time, symptom burden and test-retest reliability. ERJ Open Res. 2024 Jul; 10(4). Patel S, Sylvester KP, Wu Z, Rhamie S, Dickel P, Maher TM, Molyneaux PL, Calverley PMA, Man WD. PMID: 39104963; PMCID: PMC11299002.
      View in: PubMed   Mentions:
    10. Modified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosis. ERJ Open Res. 2024 Jul; 10(4). Kreuter M, Lee JS, Tzouvelekis A, Oldham JM, Molyneaux PL, Weycker D, Atwood M, Samara K, Kirchgässler KU, Maher TM. PMID: 39076530; PMCID: PMC11284599.
      View in: PubMed   Mentions:
    11. Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial. ERJ Open Res. 2024 Jul; 10(4). Maher TM, Jenkins RG, Cottin V, Nishioka Y, Noth I, Selman M, Song JW, Ittrich C, Diefenbach C, Stowasser S, White ES. PMID: 39040590; PMCID: PMC11261372.
      View in: PubMed   Mentions: 1  
    12. Competing Causes of Death in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 Jul 16. Thenappan A, Maher TM, Yazbeck L, Jenkins RG, Johnson SR, Stewart I, Oldham JM, Molyneaux PL. PMID: 39012209.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation. Lancet Respir Med. 2024 Sep; 12(9):681-692. Fainberg HP, Moodley Y, Triguero I, Corte TJ, Sand JMB, Leeming DJ, Karsdal MA, Wells AU, Renzoni E, Mackintosh J, Tan DBA, Li R, Porte J, Braybrooke R, Saini G, Johnson SR, Wain LV, Molyneaux PL, Maher TM, Stewart ID, Jenkins RG. PMID: 39025091.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. The future of clinical trials in idiopathic pulmonary fibrosis. Curr Opin Pulm Med. 2024 Sep 01; 30(5):494-499. Spagnolo P, Maher TM. PMID: 38963152; PMCID: PMC11377049.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Potential of αvβ6 and αvβ1 integrin inhibition for treatment of idiopathic pulmonary fibrosis. Expert Opin Ther Targets. 2024 Jul; 28(7):575-585. Bellani S, Molyneaux PL, Maher TM, Spagnolo P. PMID: 38949181.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    16. The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases. Matrix Biol. 2024 Sep; 132:1-9. Genovese F, Bager C, Frederiksen P, Vazquez D, Sand JMB, Jenkins RG, Maher TM, Stewart ID, Molyneaux PL, Fahy WA, Wain LV, Vestbo J, Nanthakumar C, Shaker SB, Hoyer N, Leeming DJ, George J, Trebicka J, Rasmussen DGK, Hansen MK, Cockwell P, Kremer D, Bakker SJ, Selby NM, Reese-Petersen AL, González A, Núñez J, Rossing P, Nissen NI, Boisen MK, Chen IM, Zhao L, Karsdal MA, Schuppan D. PMID: 38871093.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    17. Association between mosaic loss of chromosome Y and pulmonary fibrosis susceptibility and severity. bioRxiv. 2024 May 30. Wang D, Hadad N, Moss S, Lopez-Jimenez E, Johnson SR, Maher TM, Molyneaux PL, Zhao Y, Perry JRB, Wolters PJ, Kropski JA, Jenkins RG, Banovich NE, Stewart I. PMID: 38853935; PMCID: PMC11160640.
      View in: PubMed   Mentions:
    18. Interstitial Lung Disease: A Review. JAMA. 2024 05 21; 331(19):1655-1665. Maher TM. PMID: 38648021.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an AJRCCM Special Issue. Am J Respir Crit Care Med. 2024 05 01; 209(9):1049-1050. Maher TM, Podolanczuk AJ, Drake WP, Sime PJ, Eickelberg O, DeMeo DL, Richeldi L. PMID: 38690973; PMCID: PMC11092960.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. A Long and Winding Road: Drug Development in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 05 01; 209(9):1072-1073. Spagnolo P, Maher TM. PMID: 38445949; PMCID: PMC11092949.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Cough Severity Visual Analog Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 05 01; 209(9):1165-1167. Wu Z, Smith DJF, Yazbeck L, Saunders P, Smith JA, Maher TM, Molyneaux PL. PMID: 38301238; PMCID: PMC11092948.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Gazing into the Proteomic Crystal Ball: Predicting Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 05 01; 209(9):1056-1057. Lee JS, Maher TM. PMID: 38117693; PMCID: PMC11092944.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. [18F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases. J Nucl Med. 2024 Apr 01; 65(4):617-622. Porter JC, Ganeshan B, Win T, Fraioli F, Khan S, Rodriguez-Justo M, Endozo R, Shortman RI, Hoy LR, Maher TM, Groves AM. PMID: 38485275; PMCID: PMC10995524.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency. Am J Respir Crit Care Med. 2024 03 15; 209(6):647-669. Raghu G, Ghazipura M, Fleming TR, Aronson KI, Behr J, Brown KK, Flaherty KR, Kazerooni EA, Maher TM, Richeldi L, Lasky JA, Swigris JJ, Busch R, Garrard L, Ahn DH, Li J, Puthawala K, Rodal G, Seymour S, Weir N, Danoff SK, Ettinger N, Goldin J, Glassberg MK, Kawano-Dourado L, Khalil N, Lancaster L, Lynch DA, Mageto Y, Noth I, Shore JE, Wijsenbeek M, Brown R, Grogan D, Ivey D, Golinska P, Karimi-Shah B, Martinez FJ. PMID: 38174955.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    25. Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis. ERJ Open Res. 2024 Jan; 10(1). Guillen-Guio B, Paynton ML, Allen RJ, Chin DPW, Donoghue LJ, Stockwell A, Leavy OC, Hernandez-Beeftink T, Reynolds C, Cullinan P, Martinez F, Booth HL, Fahy WA, Hall IP, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Sayers I, Tobin MD, Whyte MKB, Adegunsoye A, Kaminski N, Ma SF, Strek ME, Zhang Y, Fingerlin TE, Molina-Molina M, Neighbors M, Sheng XR, Oldham JM, Maher TM, Molyneaux PL, Flores C, Noth I, Schwartz DA, Yaspan BL, Jenkins RG, Wain LV, Hollox EJ. PMID: 38375425; PMCID: PMC10875457.
      View in: PubMed   Mentions: 2  
    26. Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report. Am J Respir Crit Care Med. 2024 02 15; 209(4):362-373. Montesi SB, Gomez CR, Beers M, Brown R, Chattopadhyay I, Flaherty KR, Garcia CK, Gomperts B, Hariri LP, Hogaboam CM, Jenkins RG, Kaminski N, Kim GHJ, Königshoff M, Kolb M, Kotton DN, Kropski JA, Lasky J, Magin CM, Maher TM, McCormick M, Moore BB, Nickerson-Nutter C, Oldham J, Podolanczuk AJ, Raghu G, Rosas I, Rowe SM, Schmidt WT, Schwartz D, Shore JE, Spino C, Craig JM, Martinez FJ. PMID: 38113442; PMCID: PMC10878386.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. Eur Respir J. 2024 Feb; 63(2). Wijsenbeek M, Swigris JJ, Inoue Y, Kreuter M, Maher TM, Suda T, Baldwin M, Mueller H, Rohr KB, Flaherty KR, INBUILD Trial Investigators. PMID: 38135442; PMCID: PMC10831140.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Estimating the effect of nintedanib on forced vital capacity in children and adolescents with fibrosing interstitial lung disease using a Bayesian dynamic borrowing approach. Pediatr Pulmonol. 2024 Apr; 59(4):1038-1046. Maher TM, Brown KK, Cunningham S, DeBoer EM, Deterding R, Fiorino EK, Griese M, Schwerk N, Warburton D, Young LR, Gahlemann M, Voss F, Stock C, InPedILD trial investigators. PMID: 38289091.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis. ERJ Open Res. 2024 Jan; 10(1). Ford P, Kreuter M, Brown KK, Wuyts WA, Wijsenbeek M, Israël-Biet D, Hubbard R, Nathan SD, Nunes H, Penninckx B, Prasad N, Seghers I, Spagnolo P, Verbruggen N, Hirani N, Behr J, Kaner RJ, Maher TM. PMID: 38288082; PMCID: PMC10823372.
      View in: PubMed   Mentions:
    30. Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis. medRxiv. 2024 Jan 15. Leavy OC, Goemans AF, Stockwell AD, Allen RJ, Guillen-Guio B, Hernandez-Beeftink T, Adegunsoye A, Booth HL, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative, Cullinan P, Fahy WA, Fingerlin TE, Virk HS, Hall IP, Hart SP, Hill MR, Hirani N, Hubbard RB, Kaminski N, Ma SF, McAnulty RJ, Sheng XR, Millar AB, Molina-Molina M, Navaratnam V, Neighbors M, Parfrey H, Saini G, Sayers I, Strek ME, Tobin MD, Whyte MK, Zhang Y, Maher TM, Molyneaux PL, Oldham JM, Yaspan BL, Flores C, Martinez F, Reynolds CJ, Schwartz DA, Noth I, Jenkins RG, Wain LV. PMID: 38293162; PMCID: PMC10827242.
      View in: PubMed   Mentions:
    31. Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial. Lancet Respir Med. 2024 Apr; 12(4):273-280. Wu Z, Spencer LG, Banya W, Westoby J, Tudor VA, Rivera-Ortega P, Chaudhuri N, Jakupovic I, Patel B, Thillai M, West A, Wijsenbeek M, Maher TM, Smith JA, Molyneaux PL. PMID: 38237620.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    32. Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society Report. Ann Am Thorac Soc. 2024 Jan; 21(1):1-11. Vukmirovic M, Benam KH, Rose JJ, Turner S, Magin CM, Lagares D, Cohen AH, Kaminski N, Hirota JA, Maher TM, Konigshoff M, Mallampalli RK, Sheppard D, Tarran R, Gomer RH, Kenyon NJ, Morris D, Hobbie S, Raju SV, Petrache I, Watkins T, Kumar R, Lam WA, Sherer T, Hecker L. PMID: 37903340; PMCID: PMC10867911.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung Diseases. Am J Respir Crit Care Med. 2023 11 01; 208(9):975-982. Barnett JL, Maher TM, Quint JK, Adamson A, Wu Z, Smith DJF, Rawal B, Nair A, Walsh SLF, Desai SR, George PM, Kokosi M, Jenkins G, Kouranos V, Renzoni EA, Rice A, Nicholson AG, Chua F, Wells AU, Molyneaux PL, Devaraj A. PMID: 37672028.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial. Eur Respir J. 2023 10; 62(4). Molina-Molina M, Shull JG, Vicens-Zygmunt V, Rivera-Ortega P, Antoniou K, Bonella F, Renzoni E, Russell AM, Maher TM, Vancheri A, Bachs A, Avilés V, Palma J, Bermudo G, Suarez-Cuartin G, Tebé C, Rigo-Bonnin R, Montes-Worboys A, Wijsenbeek M, Vancheri C. PMID: 37857429; PMCID: PMC10586233.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    35. Lung extracellular matrix modulates KRT5+ basal cell activity in pulmonary fibrosis. Nat Commun. 2023 09 27; 14(1):6039. Hewitt RJ, Puttur F, Gaboriau DCA, Fercoq F, Fresquet M, Traves WJ, Yates LL, Walker SA, Molyneaux PL, Kemp SV, Nicholson AG, Rice A, Roberts E, Lennon R, Carlin LM, Byrne AJ, Maher TM, Lloyd CM. PMID: 37758700; PMCID: PMC10533905.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    36. Ziritaxestat and Lung Function in Idiopathic Pulmonary Fibrosis-Reply. JAMA. 2023 09 12; 330(10):973-974. Maher TM, Ford P, Wijsenbeek MS. PMID: 37698565.
      View in: PubMed   Mentions: 1     Fields:    
    37. The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE Study. Ann Am Thorac Soc. 2023 09; 20(9):1267-1273. Saunders P, Wu Z, Fahy WA, Stewart ID, Saini G, Smith DJF, Braybrooke R, Stock C, Renzoni EA, Johnson SR, Jenkins RG, Belvisi MG, Smith JA, Maher TM, Molyneaux PL. PMID: 37159951; PMCID: PMC10502892.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD). BMJ Open Respir Res. 2023 09; 10(1). Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Coeck C, Schlecker C, Voss F, Wachtlin D, Martinez FJ. PMID: 37709661; PMCID: PMC10503394.
      View in: PubMed   Mentions: Translation:HumansCTClinical Trials
    39. Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis. Respirology. 2023 Dec; 28(12):1147-1153. Maher TM, Stowasser S, Voss F, Bendstrup E, Kreuter M, Martinez FJ, Sime PJ, Stock C. PMID: 37646126.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF). BMJ Open Respir Res. 2023 08; 10(1). Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, Oldham JM, Valenzuela C, Gordat M, Liu Y, Stowasser S, Zoz DF, Wijsenbeek MS. PMID: 37597969; PMCID: PMC10441083.
      View in: PubMed   Mentions: 3  Translation:HumansCTClinical Trials
    41. Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis. medRxiv. 2023 Jul 24. Guillen-Guio B, Paynton ML, Allen RJ, Chin DPW, Donoghue LJ, Stockwell A, Leavy OC, Hernandez-Beeftink T, Reynolds C, Cullinan P, Martinez F, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative, Booth HL, Fahy WA, Hall IP, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Sayers I, Tobin MD, Whyte MKB, Adegunsoye A, Kaminski N, Shwu-Fan M, Strek ME, Zhang Y, Fingerlin TE, Molina-Molina M, Neighbors M, Sheng XR, Oldham JM, Maher TM, Molyneaux PL, Flores C, Noth I, Schwartz DA, Yaspan BL, Jenkins RG, Wain LV, Hollox EJ. PMID: 37546732; PMCID: PMC10402235.
      View in: PubMed   Mentions:
    42. Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis. ERJ Open Res. 2023 Jul; 9(4). Oldham JM, Johnson KW, Albers GJ, Calamita E, Mah J, Ghai P, Hewitt RJ, Maher TM, Molyneaux PL, Huang M, Byrne AJ. PMID: 37465557; PMCID: PMC10350676.
      View in: PubMed   Mentions: 2  
    43. PCSK6 and Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 06 01; 207(11):1515-1524. Oldham JM, Allen RJ, Lorenzo-Salazar JM, Molyneaux PL, Ma SF, Joseph C, Kim JS, Guillen-Guio B, Hernández-Beeftink T, Kropski JA, Huang Y, Lee CT, Adegunsoye A, Pugashetti JV, Linderholm AL, Vo V, Strek ME, Jou J, Muñoz-Barrera A, Rubio-Rodriguez LA, Hubbard R, Hirani N, Whyte MKB, Hart S, Nicholson AG, Lancaster L, Parfrey H, Rassl D, Wallace W, Valenzi E, Zhang Y, Mychaleckyj J, Stockwell A, Kaminski N, Wolters PJ, Molina-Molina M, Banovich NE, Fahy WA, Martinez FJ, Hall IP, Tobin MD, Maher TM, Blackwell TS, Yaspan BL, Jenkins RG, Flores C, Wain LV, Noth I. PMID: 36780644; PMCID: PMC10263132.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    44. Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations. ERJ Open Res. 2023 May; 9(3). Jones S, Flewett M, Flewett R, Lee S, Vick B, Thompson M, Pinnetti S, Zoz DF, Hoffmann-Vold AM, Kreuter M, Maher TM. PMID: 37260456; PMCID: PMC10227627.
      View in: PubMed   Mentions: 1  
    45. The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study. Eur Respir J. 2023 05; 61(5). Reynolds CJ, Del Greco M F, Allen RJ, Flores C, Jenkins RG, Maher TM, Molyneaux PL, Noth I, Oldham JM, Wain LV, An J, Ong JS, MacGregor S, Yates TA, Cullinan P, Minelli C. PMID: 37080571; PMCID: PMC10209472.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    46. Nalbuphine Tablets for Cough in Patients with Idiopathic Pulmonary Fibrosis. NEJM Evid. 2023 Aug; 2(8):EVIDoa2300083. Maher TM, Avram C, Bortey E, Hart SP, Hirani N, Molyneux PL, Porter JC, Smith JA, Sciascia T. PMID: 38320144.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    47. Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease. Chest. 2023 11; 164(5):1232-1242. Myall KJ, West AG, Martinovic JL, Lam JL, Roque D, Wu Z, Maher TM, Molyneaux PL, Suh ES, Kent BD. PMID: 37187434.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials. JAMA. 2023 05 09; 329(18):1567-1578. Maher TM, Ford P, Brown KK, Costabel U, Cottin V, Danoff SK, Groenveld I, Helmer E, Jenkins RG, Milner J, Molenberghs G, Penninckx B, Randall MJ, Van Den Blink B, Fieuw A, Vandenrijn C, Rocak S, Seghers I, Shao L, Taneja A, Jentsch G, Watkins TR, Wuyts WA, Kreuter M, Verbruggen N, Prasad N, Wijsenbeek MS, ISABELA 1 and 2 Investigators. PMID: 37159034; PMCID: PMC10170340.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    49. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology (Oxford). 2023 05 02; 62(5):1877-1886. Roofeh D, Brown KK, Kazerooni EA, Tashkin D, Assassi S, Martinez F, Wells AU, Raghu G, Denton CP, Chung L, Hoffmann-Vold AM, Distler O, Johannson KA, Allanore Y, Matteson EL, Kawano-Dourado L, Pauling JD, Seibold JR, Volkmann ER, Walsh SLF, Oddis CV, White ES, Barratt SL, Bernstein EJ, Domsic RT, Dellaripa PF, Conway R, Rosas I, Bhatt N, Hsu V, Ingegnoli F, Kahaleh B, Garcha P, Gupta N, Khanna S, Korsten P, Lin C, Mathai SC, Strand V, Doyle TJ, Steen V, Zoz DF, Ovalles-Bonilla J, Rodriguez-Pinto I, Shenoy PD, Lewandoski A, Belloli E, Lescoat A, Nagaraja V, Ye W, Huang S, Maher T, Khanna D. PMID: 36173318; PMCID: PMC10152284.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial. Rheumatology (Oxford). 2023 05 02; 62(5):1870-1876. Denton CP, Goh NS, Humphries SM, Maher TM, Spiera R, Devaraj A, Ho L, Stock C, Erhardt E, Alves M, Wells AU. PMID: 36111858; PMCID: PMC10152288.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    51. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. Am J Respir Crit Care Med. 2023 05 01; 207(9):1194-1202. Peljto AL, Blumhagen RZ, Walts AD, Cardwell J, Powers J, Corte TJ, Dickinson JL, Glaspole I, Moodley YP, Vasakova MK, Bendstrup E, Davidsen JR, Borie R, Crestani B, Dieude P, Bonella F, Costabel U, Gudmundsson G, Donnelly SC, Egan J, Henry MT, Keane MP, Kennedy MP, McCarthy C, McElroy AN, Olaniyi JA, O'Reilly KMA, Richeldi L, Leone PM, Poletti V, Puppo F, Tomassetti S, Luzzi V, Kokturk N, Mogulkoc N, Fiddler CA, Hirani N, Jenkins RG, Maher TM, Molyneaux PL, Parfrey H, Braybrooke R, Blackwell TS, Jackson PD, Nathan SD, Porteous MK, Brown KK, Christie JD, Collard HR, Eickelberg O, Foster EE, Gibson KF, Glassberg M, Kass DJ, Kropski JA, Lederer D, Linderholm AL, Loyd J, Mathai SK, Montesi SB, Noth I, Oldham JM, Palmisciano AJ, Reichner CA, Rojas M, Roman J, Schluger N, Shea BS, Swigris JJ, Wolters PJ, Zhang Y, Prele CMA, Enghelmayer JI, Otaola M, Ryerson CJ, Salinas M, Sterclova M, Gebremariam TH, Myllärniemi M, Carbone RG, Furusawa H, Hirose M, Inoue Y, Miyazaki Y, Ohta K, Ohta S, Okamoto T, Kim DS, Pardo A, Selman M, Aranda AU, Park MS, Park JS, Song JW, Molina-Molina M, Planas-Cerezales L, Westergren-Thorsson G, Smith AV, Manichaikul AW, Kim JS, Rich SS, Oelsner EC, Barr RG, Rotter JI, Dupuis J, O'Connor G, Vasan RS, Cho MH, Silverman EK, Schwarz MI, Steele MP, Lee JS, Yang IV, Fingerlin TE, Schwartz DA. PMID: 36602845; PMCID: PMC10161752.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    52. Knowledge gaps in fibrotic interstitial lung disease in pan-Asian populations: data not missing at random? Lancet Respir Med. 2023 06; 11(6):502-504. Chua F, Low S, Chai GT, Inoue Y, Ong V, Wongkarnjana A, Kawkitinarong K, Song JW, Hamid ZA, Aziz AA, Campomanes M, Maher TM, Molyneaux PL, Syakirin S. PMID: 37028437.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort study. Respirology. 2023 07; 28(7):649-658. Nolan CM, Schofield SJ, Maddocks M, Patel S, Barker RE, Walsh JA, Polgar O, George PM, Molyneaux PL, Maher TM, Cullinan P, Man WD. PMID: 36958946.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial. Respir Res. 2023 Mar 09; 24(1):71. Kreuter M, Bendstrup E, Jouneau S, Maher TM, Inoue Y, Miede C, Lievens D, Crestani B. PMID: 36894966; PMCID: PMC9999543.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial. Eur Respir J. 2023 03; 61(3). Strambu IR, Seemayer CA, Fagard LMA, Ford PA, Van der Aa TAK, de Haas-Amatsaleh AA, Modgill V, Santermans E, Sondag EN, Helmer EG, Maher TM, Costabel U, Cottin V. PMID: 36328358; PMCID: PMC9978158.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    56. Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis. Eur Respir Rev. 2023 Mar 31; 32(167). Kolb M, Crestani B, Maher TM. PMID: 36813290; PMCID: PMC9949383.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    57. Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford). 2023 02 06; 62(SI):SI43-SI53. Kreuter M, Hoffmann-Vold AM, Matucci-Cerinic M, Saketkoo LA, Highland KB, Wilson H, Alves M, Erhardt E, Schoof N, Maher TM. PMID: 35640959; PMCID: PMC9910566.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    58. Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression. RMD Open. 2023 02; 9(1). Khanna D, Maher TM, Volkmann ER, Allanore Y, Smith V, Assassi S, Kreuter M, Hoffmann-Vold AM, Kuwana M, Stock C, Alves M, Sambevski S, Denton CP. PMID: 36796874; PMCID: PMC9936273.
      View in: PubMed   Mentions: 6  Translation:Humans
    59. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis. Respirology. 2023 05; 28(5):455-464. van der Vis JJ, Prasse A, Renzoni EA, Stock CJW, Caliskan C, Maher TM, Bonella F, Borie R, Crestani B, Petrek M, Wuyts WA, Wind AE, Molyneaux PL, Grutters JC, van Moorsel CHM. PMID: 36571111.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    60. Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis. J Comp Eff Res. 2022 Dec 20. Richeldi L, Azuma A, Cottin V, Hesslinger C, Stowasser S, Valenzuela C, Wijsenbeek MS, Zoz DF, Voss F, Maher TM. PMID: 36537726; PMCID: PMC10288937.
      View in: PubMed   Mentions: 1     Fields:    
    61. A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease. Respir Res. 2022 Nov 11; 23(1):307. Maher TM, Schiffman C, Kreuter M, Moor CC, Nathan SD, Axmann J, Belloni P, Bengus M, Gilberg F, Kirchgaessler KU, Wijsenbeek MS. PMID: 36369156; PMCID: PMC9651119.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    62. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial. Lancet Respir Med. 2023 01; 11(1):45-54. Maher TM, Tudor VA, Saunders P, Gibbons MA, Fletcher SV, Denton CP, Hoyles RK, Parfrey H, Renzoni EA, Kokosi M, Wells AU, Ashby D, Szigeti M, Molyneaux PL, RECITAL Investigators. PMID: 36375479.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    63. Tackling the Neuropathic Cough of Idiopathic Pulmonary Fibrosis (IPF): More Needs to be Done. Lung. 2022 12; 200(6):673-675. Chung KF, Birring SS, Morice AH, McGarvey LP, Mazzone SB, Maher TM, Dicpinigaitis PV. PMID: 36348052.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    64. Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort. Lancet Digit Health. 2022 12; 4(12):e862-e872. Fainberg HP, Oldham JM, Molyneau PL, Allen RJ, Kraven LM, Fahy WA, Porte J, Braybrooke R, Saini G, Karsdal MA, Leeming DJ, Sand JMB, Triguero I, Oballa E, Wells AU, Renzoni E, Wain LV, Noth I, Maher TM, Stewart ID, Jenkins RG. PMID: 36333179.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    65. Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis. ERJ Open Res. 2022 Oct; 8(4). Maher TM, Schlecker C, Luedtke D, Bossert S, Zoz DF, Schultz A. PMID: 36299369; PMCID: PMC9589333.
      View in: PubMed   Mentions: 3  
    66. Home monitoring in interstitial lung diseases. Lancet Respir Med. 2023 01; 11(1):97-110. Wijsenbeek MS, Moor CC, Johannson KA, Jackson PD, Khor YH, Kondoh Y, Rajan SK, Tabaj GC, Varela BE, van der Wal P, van Zyl-Smit RN, Kreuter M, Maher TM. PMID: 36206780.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    67. Genome-wide Enrichment of TERT Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino Ancestry. Am J Respir Crit Care Med. 2022 10 01; 206(7):903-905. Zhang D, Povysil G, Newton CA, Maher TM, Molyneaux PL, Noth I, Martinez FJ, Raghu G, Todd JL, Palmer SM, Platt A, Petrovski S, Goldstein DB, Garcia CK. PMID: 35666822; PMCID: PMC9799274.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    68. Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice. Am J Respir Crit Care Med. 2022 09 01; 206(5):649-650. Molyneaux PL, Maher TM. PMID: 35584340; PMCID: PMC9716918.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    69. A clinical short-cut to identifying short telomeres in idiopathic pulmonary fibrosis? Respirology. 2022 11; 27(11):916-917. Maher TM. PMID: 36031719.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    70. Trial of a Phosphodiesterase 4 Inhibitor for Idiopathic Pulmonary Fibrosis. Reply. N Engl J Med. 2022 08 25; 387(8):762. Richeldi L, Stowasser S, Maher TM. PMID: 36001725.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study. Lancet Respir Med. 2023 01; 11(1):65-73. Allen RJ, Oldham JM, Jenkins DA, Leavy OC, Guillen-Guio B, Melbourne CA, Ma SF, Jou J, Kim JS, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative, Fahy WA, Oballa E, Hubbard RB, Navaratnam V, Braybrooke R, Saini G, Roach KM, Tobin MD, Hirani N, Whyte MKB, Kaminski N, Zhang Y, Martinez FJ, Linderholm AL, Adegunsoye A, Strek ME, Maher TM, Molyneaux PL, Flores C, Noth I, Gisli Jenkins R, Wain LV. PMID: 35985358; PMCID: PMC10077113.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    72. Interstitial lung diseases. Lancet. 2022 09 03; 400(10354):769-786. Wijsenbeek M, Suzuki A, Maher TM. PMID: 35964592.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    73. Biomarkers for Interstitial Lung Abnormalities: A Stepping-stone Toward Idiopathic Pulmonary Fibrosis Prevention? Am J Respir Crit Care Med. 2022 08 01; 206(3):244-246. Maher TM. PMID: 35580066; PMCID: PMC9890254.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022 08 01; 206(3):247-259. Cottin V, Tomassetti S, Valenzuela C, Walsh SLF, Antoniou KM, Bonella F, Brown KK, Collard HR, Corte TJ, Flaherty KR, Johannson KA, Kolb M, Kreuter M, Inoue Y, Jenkins RG, Lee JS, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nathan SD, Poletti V, Quadrelli S, Raghu G, Rajan SK, Ravaglia C, Remy-Jardin M, Renzoni E, Richeldi LK, Spagnolo P, Troy L, Wijsenbeek M, Wilson KC, Wuyts W, Wells AU, Ryerson CJ. PMID: 35353660.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    75. Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial. ACR Open Rheumatol. 2022 Oct; 4(10):837-844. Assassi S, Distler O, Allanore Y, Ogura T, Varga J, Vettori S, Crestani B, Voss F, Alves M, Stowasser S, Maher TM, SENSCIS trial investigators. PMID: 35852465; PMCID: PMC9555199.
      View in: PubMed   Mentions: 5  
    76. Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects. Respir Res. 2022 Jul 05; 23(1):178. Maher TM, Bourdin A, Volkmann ER, Vettori S, Distler JHW, Alves M, Stock C, Distler O. PMID: 35790961; PMCID: PMC9258095.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    77. Rare and Common Variants in KIF15 Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2022 07 01; 206(1):56-69. Zhang D, Povysil G, Kobeissy PH, Li Q, Wang B, Amelotte M, Jaouadi H, Newton CA, Maher TM, Molyneaux PL, Noth I, Martinez FJ, Raghu G, Todd JL, Palmer SM, Haefliger C, Platt A, Petrovski S, Garcia JA, Goldstein DB, Garcia CK. PMID: 35417304; PMCID: PMC9954334.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    78. Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis. Front Med (Lausanne). 2022; 9:897102. Molina-Molina M, Kreuter M, Cottin V, Corte TJ, Gilberg F, Kirchgaessler KU, Axmann J, Maher TM. PMID: 35783648; PMCID: PMC9247211.
      View in: PubMed   Mentions: 1  
    79. Lung function trajectory in progressive fibrosing interstitial lung disease. Eur Respir J. 2022 06; 59(6). Oldham JM, Lee CT, Wu Z, Bowman WS, Pugashetti JV, Dao N, Tonkin J, Seede H, Echt G, Adegunsoye A, Chua F, Maher TM, Garcia CK, Strek ME, Newton CA, Molyneaux PL. PMID: 34737223; PMCID: PMC10039317.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    80. CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort. Am J Respir Crit Care Med. 2022 06 15; 205(12):1440-1448. Molyneaux PL, Fahy WA, Byrne AJ, Braybrooke R, Saunders P, Toshner R, Albers G, Chua F, Renzoni EA, Wells AU, Karkera Y, Oballa E, Saini G, Nicholson AG, Jenkins RG, Maher TM. PMID: 35363592; PMCID: PMC9875897.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    81. Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis. Thorax. 2022 08; 77(8):829-833. Allen RJ, Stockwell A, Oldham JM, Guillen-Guio B, Schwartz DA, Maher TM, Flores C, Noth I, Yaspan BL, Jenkins RG, Wain LV, International IPF Genetics Consortium. PMID: 35688625; PMCID: PMC9329250.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    82. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. N Engl J Med. 2022 06 09; 386(23):2178-2187. Richeldi L, Azuma A, Cottin V, Hesslinger C, Stowasser S, Valenzuela C, Wijsenbeek MS, Zoz DF, Voss F, Maher TM, 1305-0013 Trial Investigators. PMID: 35569036.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    83. Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases. Adv Ther. 2022 07; 39(7):3392-3402. Bonella F, Cottin V, Valenzuela C, Wijsenbeek M, Voss F, Rohr KB, Stowasser S, Maher TM. PMID: 35576048; PMCID: PMC9239974.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    84. Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis. Thorax. 2023 06; 78(6):551-558. Kraven LM, Taylor AR, Molyneaux PL, Maher TM, McDonough JE, Mura M, Yang IV, Schwartz DA, Huang Y, Noth I, Ma SF, Yeo AJ, Fahy WA, Jenkins RG, Wain LV. PMID: 35534152; PMCID: PMC9643664.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    85. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022 05 01; 205(9):e18-e47. Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nicholson AG, Ryerson CJ, Strek ME, Troy LK, Wijsenbeek M, Mammen MJ, Hossain T, Bissell BD, Herman DD, Hon SM, Kheir F, Khor YH, Macrea M, Antoniou KM, Bouros D, Buendia-Roldan I, Caro F, Crestani B, Ho L, Morisset J, Olson AL, Podolanczuk A, Poletti V, Selman M, Ewing T, Jones S, Knight SL, Ghazipura M, Wilson KC. PMID: 35486072; PMCID: PMC9851481.
      View in: PubMed   Mentions: 592     Fields:    Translation:Humans
    86. Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial). Am J Respir Crit Care Med. 2022 05 01; 205(9):1084-1092. Martinez FJ, Wijsenbeek MS, Raghu G, Flaherty KR, Maher TM, Wuyts WA, Kreuter M, Kolb M, Chambers DC, Fogarty C, Mogulkoc N, Tutuncu AS, Richeldi L. PMID: 35050837.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    87. Fatum Inexorabile: Do Monocytes Predict the Fate of Interstitial Lung Abnormalities? Am J Respir Crit Care Med. 2022 04 01; 205(7):743-744. Kreuter M, Maher TM. PMID: 35148483; PMCID: PMC9836216.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    88. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2022 03; 59(3). Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. PMID: 34675050.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    89. Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management. Clin Rev Allergy Immunol. 2022 Dec; 63(3):472-489. De Zorzi E, Spagnolo P, Cocconcelli E, Balestro E, Iaccarino L, Gatto M, Benvenuti F, Bernardinello N, Doria A, Maher TM, Zanatta E. PMID: 35303257; PMCID: PMC9674769.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    90. PAciFy Cough-a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough. Trials. 2022 Mar 02; 23(1):184. Wu Z, Banya W, Chaudhuri N, Jakupovic I, Maher TM, Patel B, Spencer LG, Thillai M, West A, Westoby J, Wijsenbeek M, Smith J, Molyneaux PL. PMID: 35236391; PMCID: PMC8889046.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    91. Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2022 03 01; 205(5):550-562. McElroy AN, Invernizzi R, Laskowska JW, O'Neill A, Doroudian M, Moghoofei M, Mostafaei S, Li F, Przybylski AA, O'Dwyer DN, Bowie AG, Fallon PG, Maher TM, Hogaboam CM, Molyneaux PL, Hirani N, Armstrong ME, Donnelly SC. PMID: 34985402.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    92. Clinical Utility of Home versus Hospital Spirometry in Fibrotic Interstitial Lung Disease: Evaluation after INJUSTIS Interim Analysis. Ann Am Thorac Soc. 2022 03; 19(3):506-509. Khan F, Howard L, Hearson G, Edwards C, Barber C, Jones S, Wilson AM, Maher TM, Saini G, Stewart I, Jenkins G. PMID: 34534053.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    93. Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease. ERJ Open Res. 2022 Jan; 8(1). Boustani K, Ghai P, Invernizzi R, Hewitt RJ, Maher TM, Li QZ, Molyneaux PL, Harker JA. PMID: 35174247; PMCID: PMC8841989.
      View in: PubMed   Mentions:
    94. The role of precision medicine in interstitial lung disease. Eur Respir J. 2022 Feb 03. Maher TM, Nambiar AM, Wells AU. PMID: 35115344; PMCID: PMC9449482.
      View in: PubMed   Mentions: 11     Fields:    
    95. Effects of nintedanib by inclusion criteria for progression of interstitial lung disease. Eur Respir J. 2022 02; 59(2). Maher TM, Brown KK, Kreuter M, Devaraj A, Walsh SLF, Lancaster LH, Belloli EA, Padilla M, Behr J, Goeldner RG, Tetzlaff K, Schlenker-Herceg R, Flaherty KR, INBUILD trial investigators. PMID: 34210788; PMCID: PMC8812469.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    96. Short-term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis. Respirology. 2022 03; 27(3):202-208. Macaluso C, Boccabella C, Kokosi M, Sivarasan N, Kouranos V, George PM, Margaritopoulos G, Molyneaux PL, Chua F, Maher TM, Jenkins GR, Nicholson AG, Desai SR, Devaraj A, Wells AU, Renzoni EA, Stock CJW. PMID: 35023231; PMCID: PMC9302621.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    97. Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography. J Scleroderma Relat Disord. 2022 Oct; 7(3):168-178. Khanna D, Distler O, Cottin V, Brown KK, Chung L, Goldin JG, Matteson EL, Kazerooni EA, Walsh SL, McNitt-Gray M, Maher TM. PMID: 36211204; PMCID: PMC9537704.
      View in: PubMed   Mentions: 5  
    98. Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework. Adv Ther. 2022 02; 39(2):1045-1054. Langford B, Diamantopoulos A, Maher TM, Inoue Y, Rohr KB, Baldwin M. PMID: 34957531; PMCID: PMC8866289.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    99. Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use. Adv Ther. 2022 02; 39(2):1081-1095. Kreuter M, Maher TM, Corte TJ, Molina-Molina M, Axmann J, Gilberg F, Kirchgaessler KU, Cottin V. PMID: 34936057; PMCID: PMC8866297.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    100. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). BMJ Open Respir Res. 2021 Dec; 8(1). Corte TJ, Lancaster L, Swigris JJ, Maher TM, Goldin JG, Palmer SM, Suda T, Ogura T, Minnich A, Zhan X, Tirucherai GS, Elpers B, Xiao H, Watanabe H, Smith RA, Charles ED, Fischer A. PMID: 34969771; PMCID: PMC8718498.
      View in: PubMed   Mentions: 17  Translation:HumansCTClinical Trials
    101. Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten. Am J Respir Crit Care Med. 2021 11 01; 204(9):1010-1011. Maher TM. PMID: 34554892; PMCID: PMC8663009.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    102. Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study. Chest. 2022 03; 161(3):728-737. Nolan CM, Polgar O, Schofield SJ, Patel S, Barker RE, Walsh JA, Ingram KA, George PM, Molyneaux PL, Maher TM, Man WD. PMID: 34699771; PMCID: PMC8941605.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    103. Reply. Arthritis Rheumatol. 2021 12; 73(12):2354-2355. Maher TM, Mayes MD, Stock C, Alves M. PMID: 34105317.
      View in: PubMed   Mentions:    Fields:    
    104. DNA Methylome Alterations Are Associated with Airway Macrophage Differentiation and Phenotype during Lung Fibrosis. Am J Respir Crit Care Med. 2021 10 15; 204(8):954-966. McErlean P, Bell CG, Hewitt RJ, Busharat Z, Ogger PP, Ghai P, Albers GJ, Calamita E, Kingston S, Molyneaux PL, Beck S, Lloyd CM, Maher TM, Byrne AJ. PMID: 34280322; PMCID: PMC8534623.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    105. Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study. Eur Respir J. 2021 10; 58(4). Porter JC, Win T, Erlandsson K, Fraioli F, Rashidnasab A, Holman B, Ganeshan B, Screaton NJ, Maher TM, Endozo R, Hoath J, Shortman RI, Emond E, Thielemans K, Hutton BF, Lukey PT, Aigbirhio F, Khan S, Rodriguez-Justo M, Groves AM. PMID: 34244317.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    106. Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World. Front Med (Lausanne). 2021; 8:699644. Polke M, Kondoh Y, Wijsenbeek M, Cottin V, Walsh SLF, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte TJ, Flaherty K, Funke-Chambour M, Kolb M, Krisam J, Maher TM, Molina Molina M, Morais A, Moor CC, Morisset J, Pereira C, Quadrelli S, Selman M, Tzouvelekis A, Valenzuela C, Vancheri C, Vicens-Zygmunt V, Wälscher J, Wuyts W, Bendstrup E, Kreuter M. PMID: 34646836; PMCID: PMC8502934.
      View in: PubMed   Mentions: 5  
    107. Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era. ERJ Open Res. 2021 Jul; 7(3). Nakshbandi G, Moor CC, Johannson KA, Maher TM, Kreuter M, Wijsenbeek MS. PMID: 34471631; PMCID: PMC8256489.
      View in: PubMed   Mentions: 12  
    108. Targeting Human Herpesviruses: An Effective Strategy for Treating Idiopathic Pulmonary Fibrosis? Ann Am Thorac Soc. 2021 08; 18(8):1285-1286. Maher TM. PMID: 34328404; PMCID: PMC8513649.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    109. Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis. Eur Respir J. 2021 07; 58(1). Stewart ID, Nanji H, Figueredo G, Fahy WA, Maher TM, Ask AJ, Maharaj S, Ask K, Kolb M, Jenkins GR. PMID: 33766945; PMCID: PMC8295504.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    110. Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021 07 15; 204(2):e3-e23. Aronson KI, Danoff SK, Russell AM, Ryerson CJ, Suzuki A, Wijsenbeek MS, Bajwah S, Bianchi P, Corte TJ, Lee JS, Lindell KO, Maher TM, Martinez FJ, Meek PM, Raghu G, Rouland G, Rudell R, Safford MM, Sheth JS, Swigris JJ. PMID: 34283696; PMCID: PMC8650796.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    111. Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. Am J Respir Crit Care Med. 2021 07 15; 204(2):197-208. Huang Y, Oldham JM, Ma SF, Unterman A, Liao SY, Barros AJ, Bonham CA, Kim JS, Vij R, Adegunsoye A, Strek ME, Molyneaux PL, Maher TM, Herazo-Maya JD, Kaminski N, Moore BB, Martinez FJ, Noth I. PMID: 33689671; PMCID: PMC8650792.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    112. Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. Eur Respir J. 2021 07; 58(1). Noth I, Cottin V, Chaudhuri N, Corte TJ, Johannson KA, Wijsenbeek M, Jouneau S, Michael A, Quaresma M, Rohr KB, Russell AM, Stowasser S, Maher TM, INMARK trial investigators. PMID: 33419890; PMCID: PMC8264778.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    113. Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res. 2021 Jul 07; 22(1):197. Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, Patel H, Kreuter M. PMID: 34233665; PMCID: PMC8261998.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansPHPublic Health
    114. Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021 07 01; 204(1):74-81. Kreuter M, Lee JS, Tzouvelekis A, Oldham JM, Molyneaux PL, Weycker D, Atwood M, Kirchgaessler KU, Maher TM. PMID: 33434107; PMCID: PMC8437112.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    115. 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study. EBioMedicine. 2021 Jul; 69:103439. Juan Guardela BM, Sun J, Zhang T, Xu B, Balnis J, Huang Y, Ma SF, Molyneaux PL, Maher TM, Noth I, Michaud G, Jaitovich A, Herazo-Maya JD. PMID: 34157486; PMCID: PMC8214725.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    116. Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis. Front Immunol. 2021; 12:661811. Trachalaki A, Tsitoura E, Mastrodimou S, Invernizzi R, Vasarmidi E, Bibaki E, Tzanakis N, Molyneaux PL, Maher TM, Antoniou K. PMID: 34220810; PMCID: PMC8248801.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    117. Muscle stimulation in advanced idiopathic pulmonary fibrosis: a randomised placebo-controlled feasibility study. BMJ Open. 2021 06 02; 11(6):e048808. Nolan CM, Patel S, Barker RE, Walsh JA, Polgar O, Maddocks M, George PM, Renzoni EA, Wells AU, Molyneaux PL, Kouranos V, Chua F, Maher TM, Man WD. PMID: 34083348; PMCID: PMC8174518.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    118. Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2021 05; 57(5). Hirani N, MacKinnon AC, Nicol L, Ford P, Schambye H, Pedersen A, Nilsson UJ, Leffler H, Sethi T, Tantawi S, Gravelle L, Slack RJ, Mills R, Karmakar U, Humphries D, Zetterberg F, Keeling L, Paul L, Molyneaux PL, Li F, Funston W, Forrest IA, Simpson AJ, Gibbons MA, Maher TM. PMID: 33214209; PMCID: PMC8156151.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCTClinical Trials
    119. Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis. Commun Biol. 2021 03 23; 4(1):392. Dhindsa RS, Mattsson J, Nag A, Wang Q, Wain LV, Allen R, Wigmore EM, Ibanez K, Vitsios D, Deevi SVV, Wasilewski S, Karlsson M, Lassi G, Olsson H, Muthas D, Monkley S, Mackay A, Murray L, Young S, Haefliger C, FinnGen Consortium, Maher TM, Belvisi MG, Jenkins G, Molyneaux PL, Platt A, Petrovski S. PMID: 33758299; PMCID: PMC7988141.
      View in: PubMed   Mentions: 27  Translation:Humans
    120. Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations. Am J Respir Crit Care Med. 2021 03 15; 203(6):775-778. Leavy OC, Ma SF, Molyneaux PL, Maher TM, Oldham JM, Flores C, Noth I, Jenkins RG, Dudbridge F, Wain LV, Allen RJ. PMID: 33226834; PMCID: PMC7958523.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    121. Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2021 04; 73(4):671-676. Maher TM, Mayes MD, Kreuter M, Volkmann ER, Aringer M, Castellvi I, Cutolo M, Stock C, Schoof N, Alves M, Raghu G, SENSCIS Trial Investigators. PMID: 33142016; PMCID: PMC8048624.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    122. Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review. ERJ Open Res. 2021 Jan; 7(1). Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Distler O. PMID: 33644224; PMCID: PMC7897846.
      View in: PubMed   Mentions: 8  
    123. Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis. Respir Res. 2021 Feb 05; 22(1):38. Leeming DJ, Genovese F, Sand JMB, Rasmussen DGK, Christiansen C, Jenkins G, Maher TM, Vestbo J, Karsdal MA. PMID: 33546680; PMCID: PMC7863042.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    124. Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2021 02; 57(2). Maher TM, Costabel U, Glassberg MK, Kondoh Y, Ogura T, Scholand MB, Kardatzke D, Howard M, Olsson J, Neighbors M, Belloni P, Swigris JJ. PMID: 33008934; PMCID: PMC7859504.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    125. The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021 02 01; 203(3):339-347. Invernizzi R, Wu BG, Barnett J, Ghai P, Kingston S, Hewitt RJ, Feary J, Li Y, Chua F, Wu Z, Wells AU, George PM, Renzoni EA, Nicholson AG, Rice A, Devaraj A, Segal LN, Byrne AJ, Maher TM, Lloyd CM, Molyneaux PL. PMID: 32692582; PMCID: PMC7874329.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    126. BAL Is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study. Am J Respir Crit Care Med. 2021 01 01; 203(1):136-139. Molyneaux PL, Smith JJ, Saunders P, Chua F, Wells AU, Renzoni EA, Nicholson AG, Fahy WA, Jenkins RG, Maher TM. PMID: 32857629; PMCID: PMC7781115.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    127. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial. Lancet Respir Med. 2021 01; 9(1):96-106. Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton CP, Distler JHW, Hoffmann-Vold AM, Khanna D, Mayes MD, Raghu G, Vonk MC, Gahlemann M, Clerisme-Beaty E, Girard M, Stowasser S, Zoz D, Maher TM, SENSCIS trial investigators. PMID: 33412120.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    128. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. Pharmacol Ther. 2021 06; 222:107798. Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ. PMID: 33359599; PMCID: PMC8142468.
      View in: PubMed   Mentions: 165     Fields:    Translation:Humans
    129. Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression. Respirology. 2021 05; 26(5):461-468. Stock CJW, Hoyles RK, Daccord C, Kokosi M, Visca D, De Lauretis A, Alfieri V, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Chua F, Maher TM, Abraham DJ, Ong V, Donovan J, Sestini P, Denton CP, Wells AU, Renzoni EA. PMID: 33336433.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    130. Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial. JAMA. 2020 12 08; 324(22):2282-2291. Wilson AM, Clark AB, Cahn T, Chilvers ER, Fraser W, Hammond M, Livermore DM, Maher TM, Parfrey H, Swart AM, Stirling S, Thickett DR, Whyte M, EME-TIPAC team. PMID: 33289822; PMCID: PMC7724556.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    131. Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis. Thorax. 2021 01; 76(1):73-82. Guillotin D, Taylor AR, Platé M, Mercer PF, Edwards LM, Haggart R, Miele G, McAnulty RJ, Maher TM, Hynds RE, Jamal-Hanjani M, Marshall RP, Fisher AJ, Blanchard AD, Chambers RC. PMID: 33214245.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    132. Itaconate controls the severity of pulmonary fibrosis. Sci Immunol. 2020 Oct 23; 5(52). Ogger PP, Albers GJ, Hewitt RJ, O'Sullivan BJ, Powell JE, Calamita E, Ghai P, Walker SA, McErlean P, Saunders P, Kingston S, Molyneaux PL, Halket JM, Gray R, Chambers DC, Maher TM, Lloyd CM, Byrne AJ. PMID: 33097591; PMCID: PMC7116646.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    133. Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis. Nat Commun. 2020 09 16; 11(1):4659. John AE, Graves RH, Pun KT, Vitulli G, Forty EJ, Mercer PF, Morrell JL, Barrett JW, Rogers RF, Hafeji M, Bibby LI, Gower E, Morrison VS, Man Y, Roper JA, Luckett JC, Borthwick LA, Barksby BS, Burgoyne RA, Barnes R, Le J, Flint DJ, Pyne S, Habgood A, Organ LA, Joseph C, Edwards-Pritchard RC, Maher TM, Fisher AJ, Gudmann NS, Leeming DJ, Chambers RC, Lukey PT, Marshall RP, Macdonald SJF, Jenkins RG, Slack RJ. PMID: 32938936; PMCID: PMC7494911.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    134. Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun. 2020 Sep 11; 11(1):4680. Woodcock HV, Eley JD, Guillotin D, Platé M, Nanthakumar CB, Martufi M, Peace S, Joberty G, Poeckel D, Good RB, Taylor AR, Zinn N, Redding M, Forty EJ, Hynds RE, Swanton C, Karsdal M, Maher TM, Fisher A, Bergamini G, Marshall RP, Blanchard AD, Mercer PF, Chambers RC. PMID: 32917879; PMCID: PMC7486377.
      View in: PubMed   Mentions:    Fields:    
    135. Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial. Ann Rheum Dis. 2020 11; 79(11):1478-1484. Seibold JR, Maher TM, Highland KB, Assassi S, Azuma A, Hummers LK, Costabel U, von Wangenheim U, Kohlbrenner V, Gahlemann M, Alves M, Distler O, SENSCIS trial investigators. PMID: 32759258; PMCID: PMC7569371.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    136. The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease. Respir Res. 2020 Jul 23; 21(1):197. Hoffmann-Vold AM, Allanore Y, Bendstrup E, Bruni C, Distler O, Maher TM, Wijsenbeek M, Kreuter M. PMID: 32703199; PMCID: PMC7379834.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    137. Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact. Eur Respir J. 2020 07; 56(1). Bonifazi M, Sverzellati N, Negri E, Jacob J, Egashira R, Moser J, Piciucchi S, Mei F, De Lauretis A, Visca D, Goh N, Bonini M, Cirilli L, La Vecchia C, Chua F, Kouranos V, Margaritopoulos G, Kokosi M, Maher TM, Gasparini S, Gabrielli A, Wells AU, Renzoni EA. PMID: 32299855; PMCID: PMC7615192.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    138. Chronic hypersensitivity pneumonitis; an enigmatic and frequently fatal disease. Eur Respir Rev. 2020 Jun 30; 29(156). Maher TM. PMID: 32641390; PMCID: PMC9488850.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    139. Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? Thorax. 2020 10; 75(10):901-903. Stock CJ, Conti C, Montero-Fernandez Á, Caramori G, Molyneaux PL, George PM, Kokosi M, Kouranos V, Maher TM, Chua F, Rice A, Denton CP, Nicholson AG, Wells A, Sestini P, Renzoni EA. PMID: 32580994.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    140. Shedding light on developmental drugs for idiopathic pulmonary fibrosis. Expert Opin Investig Drugs. 2020 Aug; 29(8):797-808. Spagnolo P, Bonella F, Ryerson CJ, Tzouvelekis A, Maher TM. PMID: 32538186.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    141. Mixed Ventilatory Defects in Pulmonary Sarcoidosis: Prevalence and Clinical Features. Chest. 2020 11; 158(5):2007-2014. Kouranos V, Ward S, Kokosi MA, Castillo D, Chua F, Judge EP, Thomas S, Van Tonder F, Devaraj A, Nicholson AG, Maher TM, Renzoni EA, Wells AU. PMID: 32534908.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    142. European consensus statements for interstitial lung disease in systemic sclerosis - Authors' reply. Lancet Rheumatol. 2020 Jun; 2(6):e319-e320. Hoffmann-Vold AM, Maher TM, Distler O. PMID: 38273593.
      View in: PubMed   Mentions:    Fields:    
    143. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA. Adv Ther. 2020 07; 37(7):3292-3298. Olson AL, Maher TM, Acciai V, Mounir B, Quaresma M, Zouad-Lejour L, Wells CD, De Loureiro L. PMID: 32451950; PMCID: PMC7467408.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    144. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020 08; 8(8):750-752. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, Sverzellati N, Maher TM. PMID: 32422177; PMCID: PMC7228737.
      View in: PubMed   Mentions: 273     Fields:    Translation:HumansCellsPHPublic Health
    145. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. 2020 05; 55(5). Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler JHW, Hoffmann-Vold AM, Johnson SR, Müller Ladner U, Smith V, Volkmann ER, Maher TM. PMID: 32079645; PMCID: PMC7236865.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    146. Opportunities to diagnose fibrotic lung diseases in routine care: A primary care cohort study. Respirology. 2020 12; 25(12):1274-1282. Jones MG, Hillyar CRT, Nibber A, Chisholm A, Wilson A, Maher TM, Kaplan A, Price D, Walsh S, Richeldi L, RESPIRATORY EFFECTIVENESS GROUP'S INTERSTITIAL LUNG DISEASE WORKING GROUP. PMID: 32390252.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    147. Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to Arms. Am J Respir Crit Care Med. 2020 05 01; 201(9):1030-1032. Kreuter M, Maher TM. PMID: 31978310; PMCID: PMC7193842.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    148. Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis. Adv Ther. 2020 05; 37(5):2460-2476. Gayle A, Schoof N, Alves M, Clarke D, Raabe C, Das P, Del Galdo F, Maher TM. PMID: 32319038; PMCID: PMC7467474.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    149. Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype. Chest. 2020 08; 158(2):646-659. Inoue Y, Kaner RJ, Guiot J, Maher TM, Tomassetti S, Moiseev S, Kuwana M, Brown KK. PMID: 32268131.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    150. Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent. Eur Respir J. 2020 04; 55(4). Invernizzi R, Barnett J, Rawal B, Nair A, Ghai P, Kingston S, Chua F, Wu Z, Wells AU, Renzoni ER, Nicholson AG, Rice A, Lloyd CM, Byrne AJ, Maher TM, Devaraj A, Molyneaux PL. PMID: 31980496; PMCID: PMC7136009.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    151. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation. Eur Respir J. 2020 04; 55(4). Kreuter M, Polke M, Walsh SLF, Krisam J, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte T, Flaherty K, Funke-Chambour M, Kolb M, Kondoh Y, Maher TM, Molina Molina M, Morais A, Moor CC, Morisset J, Pereira C, Quadrelli S, Selman M, Tzouvelekis A, Valenzuela C, Vancheri C, Vicens-Zygmunt V, Wälscher J, Wuyts W, Wijsenbeek M, Cottin V, Bendstrup E. PMID: 32060068.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    152. A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor. Respir Res. 2020 Mar 26; 21(1):75. Maher TM, Simpson JK, Porter JC, Wilson FJ, Chan R, Eames R, Cui Y, Siederer S, Parry S, Kenny J, Slack RJ, Sahota J, Paul L, Saunders P, Molyneaux PL, Lukey PT, Rizzo G, Searle GE, Marshall RP, Saleem A, Kang'ombe AR, Fairman D, Fahy WA, Vahdati-Bolouri M. PMID: 32216814; PMCID: PMC7099768.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    153. Dynamics of human monocytes and airway macrophages during healthy aging and after transplant. J Exp Med. 2020 03 02; 217(3). Byrne AJ, Powell JE, O'Sullivan BJ, Ogger PP, Hoffland A, Cook J, Bonner KL, Hewitt RJ, Wolf S, Ghai P, Walker SA, Lukowski SW, Molyneaux PL, Saglani S, Chambers DC, Maher TM, Lloyd CM. PMID: 31917836; PMCID: PMC7062517.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    154. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020 03 01; 201(5):564-574. Allen RJ, Guillen-Guio B, Oldham JM, Ma SF, Dressen A, Paynton ML, Kraven LM, Obeidat M, Li X, Ng M, Braybrooke R, Molina-Molina M, Hobbs BD, Putman RK, Sakornsakolpat P, Booth HL, Fahy WA, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Whyte MKB, Zhang Y, Kaminski N, Adegunsoye A, Strek ME, Neighbors M, Sheng XR, Gudmundsson G, Gudnason V, Hatabu H, Lederer DJ, Manichaikul A, Newell JD, O'Connor GT, Ortega VE, Xu H, Fingerlin TE, Bossé Y, Hao K, Joubert P, Nickle DC, Sin DD, Timens W, Furniss D, Morris AP, Zondervan KT, Hall IP, Sayers I, Tobin MD, Maher TM, Cho MH, Hunninghake GM, Schwartz DA, Yaspan BL, Molyneaux PL, Flores C, Noth I, Jenkins RG, Wain LV. PMID: 31710517; PMCID: PMC7047454.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCells
    155. Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease. Eur Respir J. 2020 02; 55(2). Alfieri V, Crisafulli E, Visca D, Chong WH, Stock C, Mori L, de Lauretis A, Tsipouri V, Chua F, Kouranos V, Kokosi M, Hogben C, Molyneaux PL, George PM, Maher TM, Chetta AA, Sestini P, Wells AU, Renzoni EA. PMID: 31699833.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    156. Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx Trial. Eur Respir J. 2020 02; 55(2). Whitty JA, Rankin J, Visca D, Tsipouri V, Mori L, Spencer L, Adamali H, Maher TM, Hopkinson NS, Birring SS, Farquhar M, Wells AU, Sestini P, Renzoni EA. PMID: 31699838.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    157. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials. Respir Res. 2020 Jan 30; 21(1):36. Kreuter M, Wuyts WA, Wijsenbeek M, Bajwah S, Maher TM, Stowasser S, Male N, Stansen W, Schoof N, Orsatti L, Swigris J. PMID: 32000772; PMCID: PMC6990488.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    158. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatol. 2020 Feb; 2(2):e71-e83. Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, Bruni C, Carducci P, Carreira PE, Castellví I, Del Galdo F, Distler JHW, Foeldvari I, Fraticelli P, George PM, Griffiths B, Guillén-Del-Castillo A, Hamid AM, Horváth R, Hughes M, Kreuter M, Moazedi-Fuerst F, Olas J, Paul S, Rotondo C, Rubio-Rivas M, Seferian A, Tomcík M, Uzunhan Y, Walker UA, Wiesik-Szewczyk E, Distler O. PMID: 38263663.
      View in: PubMed   Mentions: 104     Fields:    
    159. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease. Clin Rheumatol. 2020 Apr; 39(4):1173-1179. Stock CJW, De Lauretis A, Visca D, Daccord C, Kokosi M, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Nihtyanova S, Chua F, Maher TM, Ong V, Abraham DJ, Denton CP, Wells AU, Wain LV, Renzoni EA. PMID: 31916109; PMCID: PMC7142048.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    160. Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study). Eur J Nucl Med Mol Imaging. 2020 04; 47(4):967-979. Lukey PT, Coello C, Gunn R, Parker C, Wilson FJ, Saleem A, Garman N, Costa M, Kendrick S, Onega M, Kang'ombe AR, Listanco A, Davies J, Ramada-Magalhaes J, Moz S, Fahy WA, Maher TM, Jenkins G, Passchier J, Marshall RP. PMID: 31814068; PMCID: PMC7075837.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    161. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 12 01; 200(11):1402-1413. Hobbs BD, Putman RK, Araki T, Nishino M, Gudmundsson G, Gudnason V, Eiriksdottir G, Zilhao Nogueira NR, Dupuis J, Xu H, O'Connor GT, Manichaikul A, Nguyen J, Podolanczuk AJ, Madahar P, Rotter JI, Lederer DJ, Barr RG, Rich SS, Ampleford EJ, Ortega VE, Peters SP, O'Neal WK, Newell JD, Bleecker ER, Meyers DA, Allen RJ, Oldham JM, Ma SF, Noth I, Jenkins RG, Maher TM, Hubbard RB, Wain LV, Fingerlin TE, Schwartz DA, Washko GR, Rosas IO, Silverman EK, Hatabu H, Cho MH, Hunninghake GM. PMID: 31339356; PMCID: PMC6884045.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    162. The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis. Int J Mol Sci. 2019 Nov 10; 20(22). Spagnolo P, Molyneaux PL, Bernardinello N, Cocconcelli E, Biondini D, Fracasso F, Tiné M, Saetta M, Maher TM, Balestro E. PMID: 31717661; PMCID: PMC6888416.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    163. Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 11 01; 200(9):1146-1153. Walsh SLF, Lederer DJ, Ryerson CJ, Kolb M, Maher TM, Nusser R, Poletti V, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown KK, Corte TJ, Cottin V, Crestani B, Flaherty KR, Glaspole IN, Grutters J, Inoue Y, Kondoh Y, Kreuter M, Johannson KA, Ley B, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts WA, Wells AU. PMID: 31241357.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    164. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply. N Engl J Med. 2019 10 17; 381(16):1596-1597. Distler O, Gahlemann M, Maher TM. PMID: 31618556.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    165. Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease. Expert Rev Clin Immunol. 2019 10; 15(10):1009-1017. Distler O, Volkmann ER, Hoffmann-Vold AM, Maher TM. PMID: 31566449.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    166. Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis. Eur Respir J. 2019 09; 54(3). Jacob J, Bartholmai BJ, van Moorsel CHM, Rajagopalan S, Devaraj A, van Es HW, Moua T, van Beek FT, Clay R, Veltkamp M, Kokosi M, de Lauretis A, Judge EP, Jacob TM, Peikert T, Karwoski R, Maldonado F, Renzoni E, Maher TM, Altmann A, Wells AU. PMID: 31196945; PMCID: PMC6860992.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    167. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2020 02; 8(2):147-157. Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Samara K, Gilberg F, Cottin V. PMID: 31578169.
      View in: PubMed   Mentions: 216     Fields:    Translation:HumansCTClinical Trials
    168. Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design. Adv Ther. 2019 11; 36(11):3059-3070. Santermans E, Ford P, Kreuter M, Verbruggen N, Meyvisch P, Wuyts WA, Brown KK, Lederer DJ, Byrne AJ, Molyneaux PL, Sivananthan A, Moor CC, Maher TM, Wijsenbeek M. PMID: 31565781; PMCID: PMC6822798.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    169. Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis. Sci Transl Med. 2019 09 25; 11(511). Ng B, Dong J, D'Agostino G, Viswanathan S, Widjaja AA, Lim WW, Ko NSJ, Tan J, Chothani SP, Huang B, Xie C, Pua CJ, Chacko AM, Guimarães-Camboa N, Evans SM, Byrne AJ, Maher TM, Liang J, Jiang D, Noble PW, Schafer S, Cook SA. PMID: 31554736.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansAnimalsCells
    170. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. Eur Respir J. 2019 09; 54(3). Wollin L, Distler JHW, Redente EF, Riches DWH, Stowasser S, Schlenker-Herceg R, Maher TM, Kolb M. PMID: 31285305; PMCID: PMC6751387.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansAnimalsCells
    171. Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat. Respir Res. 2019 Sep 06; 20(1):205. Maher TM, Strek ME. PMID: 31492155; PMCID: PMC6731623.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    172. King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference. Eur Respir J. 2019 09; 54(3). Nolan CM, Birring SS, Maddocks M, Maher TM, Patel S, Barker RE, Jones SE, Walsh JA, Wynne SC, George PM, Man WD. PMID: 31221807.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    173. Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. Eur Respir J. 2019 07; 54(1). Barnett J, Molyneaux PL, Rawal B, Abdullah R, Hare SS, Vancheeswaran R, Desai SR, Maher TM, Wells AU, Devaraj A. PMID: 31164428.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    174. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study. Lancet Respir Med. 2019 09; 7(9):771-779. Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Rohr KB, Michael A, Ittrich C, Diefenbach C, Jenkins RG, INMARK trial investigators. PMID: 31326319.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    175. The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 07 15; 200(2):209-219. Allden SJ, Ogger PP, Ghai P, McErlean P, Hewitt R, Toshner R, Walker SA, Saunders P, Kingston S, Molyneaux PL, Maher TM, Lloyd CM, Byrne AJ. PMID: 31051082; PMCID: PMC6635794.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    176. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 07 15; 200(2):199-208. Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA. PMID: 31034279; PMCID: PMC6635791.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    177. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort. Respir Res. 2019 Jul 12; 20(1):148. Organ LA, Duggan AR, Oballa E, Taggart SC, Simpson JK, Kang'ombe AR, Braybrooke R, Molyneaux PL, North B, Karkera Y, Leeming DJ, Karsdal MA, Nanthakumar CB, Fahy WA, Marshall RP, Jenkins RG, Maher TM. PMID: 31299951; PMCID: PMC6624898.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    178. Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation. Ann Am Thorac Soc. 2019 07; 16(7):927-930. Maher TM, Lancaster LH, Jouneau S, Morrison L, Lederer DJ, Molina-Molina M, Bendstrup E, Kirchgaessler KU, Gilberg F, Axmann J, Petzinger U, Noble PW. PMID: 30950636; PMCID: PMC6600834.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    179. Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options. Drugs Aging. 2019 06; 36(6):485-492. Hewitt RJ, Maher TM. PMID: 30864023.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    180. In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality. Eur Respir J. 2019 05; 53(5). Mackintosh JA, Desai SR, Adamali H, Patel K, Chua F, Devaraj A, Kouranos V, Kokosi M, Margaritopoulos G, Renzoni EA, Wells AU, Molyneaux PL, Kumar S, Maher TM, George PM. PMID: 30923184.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    181. Management of Fibrosing Interstitial Lung Diseases. Adv Ther. 2019 07; 36(7):1518-1531. Maher TM, Wuyts W. PMID: 31119691; PMCID: PMC6824393.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    182. Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2). BMJ Open Respir Res. 2019; 6(1):e000422. Maher TM, Kreuter M, Lederer DJ, Brown KK, Wuyts W, Verbruggen N, Stutvoet S, Fieuw A, Ford P, Abi-Saab W, Wijsenbeek M. PMID: 31179008; PMCID: PMC6530501.
      View in: PubMed   Mentions: 39  Translation:HumansCTClinical Trials
    183. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. N Engl J Med. 2019 06 27; 380(26):2518-2528. Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM, SENSCIS Trial Investigators. PMID: 31112379.
      View in: PubMed   Mentions: 494     Fields:    Translation:Humans
    184. Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort. Eur Respir J. 2019 05; 53(5). Stewart I, McKeever T, Braybrooke R, Oballa E, Simpson JK, Maher TM, Marshall RP, Lukey PT, Fahy WA, Jenkins G, Saini G. PMID: 30846471.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    185. Can monocytes predict prognosis of idiopathic pulmonary fibrosis? Lancet Respir Med. 2019 06; 7(6):467-469. Kreuter M, Maher TM. PMID: 30935880.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    186. A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis. Eur Respir J. 2019 03; 53(3). Lukey PT, Harrison SA, Yang S, Man Y, Holman BF, Rashidnasab A, Azzopardi G, Grayer M, Simpson JK, Bareille P, Paul L, Woodcock HV, Toshner R, Saunders P, Molyneaux PL, Thielemans K, Wilson FJ, Mercer PF, Chambers RC, Groves AM, Fahy WA, Marshall RP, Maher TM. PMID: 30765508.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    187. Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use. Pharmacoecon Open. 2019 Mar; 3(1):81-91. Diamantopoulos A, Maher TM, Schoof N, Esser D, LeReun C. PMID: 29943133; PMCID: PMC6393274.
      View in: PubMed   Mentions: 3  
    188. The King's Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference. BMJ Open Respir Res. 2019; 6(1):e000363. Sinha A, Patel AS, Siegert RJ, Bajwah S, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS. PMID: 30956799; PMCID: PMC6424243.
      View in: PubMed   Mentions: 22  Translation:Humans
    189. Sarcoidosis in the UK: insights from British Thoracic Society registry data. BMJ Open Respir Res. 2019; 6(1):e000357. Thillai M, Chang W, Chaudhuri N, Forrest I, Ho LP, Lines S, Maher TM, Spencer LG, Spiteri M, Coker R. PMID: 30956798; PMCID: PMC6424275.
      View in: PubMed   Mentions: 9  Translation:Humans
    190. The potential impact of azithromycin in idiopathic pulmonary fibrosis. Eur Respir J. 2019 02; 53(2). Macaluso C, Maritano Furcada J, Alzaher O, Chaube R, Chua F, Wells AU, Maher TM, George PM, Renzoni EA, Molyneaux PL. PMID: 30442715.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    191. Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study. Eur Respir J. 2019 02; 53(2). Nolan CM, Maddocks M, Maher TM, Banya W, Patel S, Barker RE, Jones SE, George PM, Cullinan P, Man WD. PMID: 30487200.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    192. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. QJM. 2019 02 01; 112(2):81-93. Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC. PMID: 30605544.
      View in: PubMed   Mentions: 2     Fields:    
    193. No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone. Eur Respir J. 2019 01; 53(1). Richeldi L, Fletcher S, Adamali H, Chaudhuri N, Wiebe S, Wind S, Hohl K, Baker A, Schlenker-Herceg R, Stowasser S, Maher TM. PMID: 30442716.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    194. Predicting outcomes in rheumatoid arthritis related interstitial lung disease. Eur Respir J. 2019 01; 53(1). Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, Bartholmai BJ, van Beek FT, Struik MHL, Stewart GA, Kokosi M, Egashira R, Brun AL, Cross G, Barnett J, Devaraj A, Margaritopoulos G, Karwoski R, Renzoni E, Maher TM, Wells AU. PMID: 30487199; PMCID: PMC6319797.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    195. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195. Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC. PMID: 30604506.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    196. The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun. 2019 01 02; 10(1):6. Woodcock HV, Eley JD, Guillotin D, Platé M, Nanthakumar CB, Martufi M, Peace S, Joberty G, Poeckel D, Good RB, Taylor AR, Zinn N, Redding M, Forty EJ, Hynds RE, Swanton C, Karsdal M, Maher TM, Fisher A, Bergamini G, Marshall RP, Blanchard AD, Mercer PF, Chambers RC. PMID: 30602778; PMCID: PMC6315032.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCells
    197. Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis. Am J Respir Crit Care Med. 2019 01 01; 199(1):12-21. Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G, Richeldi L, Ross BD, Schlenker-Herceg R, Sverzellati N, Wells AU, Martinez FJ, Lynch DA, Goldin J, Walsh SLF. PMID: 29986154.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    198. Regularized Latent Class Model for Joint Analysis of High-Dimensional Longitudinal Biomarkers and a Time-to-Event Outcome. Biometrics. 2019 03; 75(1):69-77. Sun J, Herazo-Maya JD, Molyneaux PL, Maher TM, Kaminski N, Zhao H. PMID: 30178494.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    199. Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis. Respir Med. 2019 01; 146:42-48. Brown KK, Flaherty KR, Cottin V, Raghu G, Inoue Y, Azuma A, Huggins JT, Richeldi L, Stowasser S, Stansen W, Schlenker-Herceg R, Maher TM, Wells AU. PMID: 30665517.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    200. Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice. ERJ Open Res. 2018 Oct; 4(4). Fletcher SV, Jones MG, Renzoni EA, Parfrey H, Hoyles RK, Spinks K, Kokosi M, Kwok A, Warburton C, Titmuss V, Thillai M, Simler N, Maher TM, Brereton CJ, Chua F, Wells AU, Richeldi L, Spencer LG. PMID: 30364342; PMCID: PMC6194204.
      View in: PubMed   Mentions: 15  
    201. Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study. ERJ Open Res. 2018 Oct; 4(4). Cottin V, Koschel D, Günther A, Albera C, Azuma A, Sköld CM, Tomassetti S, Hormel P, Stauffer JL, Strombom I, Kirchgaessler KU, Maher TM. PMID: 30364407; PMCID: PMC6194203.
      View in: PubMed   Mentions: 39  
    202. PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production. Sci Transl Med. 2018 09 26; 10(460). Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, Chioma OS, Lee G, Hassell NE, Shaginurova GI, Wang Y, Johnson JE, Kerrigan A, Mason WR, Baughman RP, Ayers GD, Bernard GR, Culver DA, Montgomery CG, Maher TM, Molyneaux PL, Noth I, Mutsaers SE, Prele CM, Peebles RS, Newcomb DC, Kaminski N, Blackwell TS, Van Kaer L, Drake WP. PMID: 30257954; PMCID: PMC6263177.
      View in: PubMed   Mentions: 148     Fields:    Translation:HumansAnimalsCells
    203. Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis. Am J Respir Crit Care Med. 2018 09 15; 198(6):767-776. Jacob J, Bartholmai BJ, Rajagopalan S, van Moorsel CHM, van Es HW, van Beek FT, Struik MHL, Kokosi M, Egashira R, Brun AL, Nair A, Walsh SLF, Cross G, Barnett J, de Lauretis A, Judge EP, Desai S, Karwoski R, Ourselin S, Renzoni E, Maher TM, Altmann A, Wells AU. PMID: 29684284; PMCID: PMC6222463.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    204. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial. BMJ Open Respir Res. 2018; 5(1):e000289. Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Cottin V. PMID: 30233802; PMCID: PMC6135451.
      View in: PubMed   Mentions: 29  
    205. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir Med. 2018 10; 6(10):759-770. Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA. PMID: 30170904.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    206. Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial. BMJ Open Respir Res. 2018; 5(1):e000325. Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Blahova Z, Wachtlin D, Diefenbach C, Jenkins RG. PMID: 30167310; PMCID: PMC6109823.
      View in: PubMed   Mentions: 8  
    207. Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views. Respiration. 2018; 96(6):514-524. Maher TM, Swigris JJ, Kreuter M, Wijsenbeek M, Cassidy N, Ireland L, Axmann J, Nathan SD. PMID: 30114692.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    208. Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis. Respiration. 2018; 96(4):314-322. Spagnolo P, Kreuter M, Maher TM, Wuyts W, Bonella F, Corte TJ, Kopf S, Weycker D, Kirchgaessler KU, Ryerson CJ. PMID: 30025392.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    209. Rapidly Progressive Cystic Lung Disease. Am J Respir Crit Care Med. 2018 07 15; 198(2):264. Rogers C, Kent-Bramer J, Devaraj A, Nicholson AG, Molyneaux PL, Wells AU, Saikia S, Maher TM, George PM. PMID: 29625015.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    210. The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review. Pharmacoeconomics. 2018 07; 36(7):779-807. Diamantopoulos A, Wright E, Vlahopoulou K, Cornic L, Schoof N, Maher TM. PMID: 29492843; PMCID: PMC5999165.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    211. Gazing into the crystal ball: can treatment response be predicted in IPF? Lancet Respir Med. 2018 08; 6(8):570-572. Kreuter M, Maher T. PMID: 30072104.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    212. Could quality be the key in connective tissue disease-associated interstitial lung disease? Respirology. 2018 Jun 13. Molyneaux PL, Maher TM. PMID: 29897157.
      View in: PubMed   Mentions:    Fields:    
    213. Improved quantitation and reproducibility in multi-PET/CT lung studies by combining CT information. EJNMMI Phys. 2018 Jun 05; 5(1):14. Holman BF, Cuplov V, Millner L, Endozo R, Maher TM, Groves AM, Hutton BF, Thielemans K. PMID: 29869186; PMCID: PMC5986691.
      View in: PubMed   Mentions: 2  
    214. Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial. Lancet Respir Med. 2018 08; 6(8):627-635. Maher TM, van der Aar EM, Van de Steen O, Allamassey L, Desrivot J, Dupont S, Fagard L, Ford P, Fieuw A, Wuyts W. PMID: 29792287.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCTClinical Trials
    215. Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK. Adv Ther. 2018 May; 35(5):724-736. Strongman H, Kausar I, Maher TM. PMID: 29644539; PMCID: PMC5960490.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    216. Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis. Respiration. 2018; 95(5):317-326. Kreuter M, Costabel U, Richeldi L, Cottin V, Wijsenbeek M, Bonella F, Bendstrup E, Maher TM, Wachtlin D, Stowasser S, Kolb M. PMID: 29414827.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    217. The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis. Respir Res. 2018 02 06; 19(1):25. Usmani OS, Biddiscombe MF, Yang S, Meah S, Oballa E, Simpson JK, Fahy WA, Marshall RP, Lukey PT, Maher TM. PMID: 29409488; PMCID: PMC5801831.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    218. The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial. Trials. 2018 Feb 05; 19(1):89. Hammond M, Clark AB, Cahn AP, Chilvers ER, Fraser WD, Livermore DM, Maher TM, Parfrey H, Swart AM, Stirling S, Thickett D, Whyte M, Wilson A. PMID: 29402332; PMCID: PMC5800095.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    219. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? Lancet Respir Med. 2018 02; 6(2):154-160. Wolters PJ, Blackwell TS, Eickelberg O, Loyd JE, Kaminski N, Jenkins G, Maher TM, Molina-Molina M, Noble PW, Raghu G, Richeldi L, Schwarz MI, Selman M, Wuyts WA, Schwartz DA. PMID: 29413083; PMCID: PMC5903445.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    220. Combination Therapy and the Start of a New Epoch for Idiopathic Pulmonary Fibrosis? Am J Respir Crit Care Med. 2018 02 01; 197(3):283-284. Maher TM. PMID: 28984465.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    221. Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease. EBioMedicine. 2018 Feb; 28:303-310. Jacob J, Song JW, Yoon HY, Cross G, Barnett J, Woo WL, Adams F, Kokosi M, Devaraj A, Renzoni E, Maher TM, Kim DS, Wells AU. PMID: 29422289; PMCID: PMC5835571.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    222. Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis. Sci Rep. 2018 01 30; 8(1):1906. Peix L, Evans IC, Pearce DR, Simpson JK, Maher TM, McAnulty RJ. PMID: 29382921; PMCID: PMC5789849.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    223. Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF). Eur J Nucl Med Mol Imaging. 2018 05; 45(5):806-815. Win T, Screaton NJ, Porter JC, Ganeshan B, Maher TM, Fraioli F, Endozo R, Shortman RI, Hurrell L, Holman BF, Thielemans K, Rashidnasab A, Hutton BF, Lukey PT, Flynn A, Ell PJ, Groves AM. PMID: 29335764; PMCID: PMC5978900.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    224. Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization. Respirology. 2018 07; 23(7):687-694. Keir GJ, Wort SJ, Kokosi M, George PM, Walsh SLF, Jacob J, Price L, Bax S, Renzoni EA, Maher TM, MacDonald P, Hansell DM, Wells AU. PMID: 29327393.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    225. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema. Respirology. 2018 06; 23(6):593-599. Jacob J, Bartholmai BJ, Rajagopalan S, Karwoski R, Nair A, Walsh SLF, Barnett J, Cross G, Judge EP, Kokosi M, Renzoni E, Maher TM, Wells AU. PMID: 29237236.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    226. Pleuroparenchymal Fibroelastosis: A Review of Histopathologic Features and the Relationship Between Histologic Parameters and Survival. Am J Surg Pathol. 2017 Dec; 41(12):1683-1689. Khiroya R, Macaluso C, Montero MA, Wells AU, Chua F, Kokosi M, Maher TM, Devaraj A, Rice A, Renzoni EA, Nicholson AG. PMID: 28877057.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    227. Towards a global initiative for fibrosis treatment (GIFT). ERJ Open Res. 2017 Oct; 3(4). Molina-Molina M, Agusti A, Crestani B, Schwartz DA, Königshoff M, Chambers RC, Maher TM, Faner R, Mora AL, Rojas M, Antoniou KM, Sellares J. PMID: 29214157; PMCID: PMC5710382.
      View in: PubMed   Mentions: 1  
    228. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med. 2017 12; 5(12):946-955. Maher TM, Oballa E, Simpson JK, Porte J, Habgood A, Fahy WA, Flynn A, Molyneaux PL, Braybrooke R, Divyateja H, Parfrey H, Rassl D, Russell AM, Saini G, Renzoni EA, Duggan AM, Hubbard R, Wells AU, Lukey PT, Marshall RP, Jenkins RG. PMID: 29150411.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    229. Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis. Respirology. 2018 05; 23(5):498-506. Nolan CM, Maddocks M, Maher TM, Canavan JL, Jones SE, Barker RE, Patel S, Jacob J, Cullinan P, Man WD. PMID: 29139195.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    230. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. Lancet Respir Med. 2017 11; 5(11):869-880. Allen RJ, Porte J, Braybrooke R, Flores C, Fingerlin TE, Oldham JM, Guillen-Guio B, Ma SF, Okamoto T, John AE, Obeidat M, Yang IV, Henry A, Hubbard RB, Navaratnam V, Saini G, Thompson N, Booth HL, Hart SP, Hill MR, Hirani N, Maher TM, McAnulty RJ, Millar AB, Molyneaux PL, Parfrey H, Rassl DM, Whyte MKB, Fahy WA, Marshall RP, Oballa E, Bossé Y, Nickle DC, Sin DD, Timens W, Shrine N, Sayers I, Hall IP, Noth I, Schwartz DA, Tobin MD, Wain LV, Jenkins RG. PMID: 29066090; PMCID: PMC5666208.
      View in: PubMed   Mentions: 129     Fields:    Translation:HumansCells
    231. Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. Lancet Respir Med. 2017 11; 5(11):857-868. Herazo-Maya JD, Sun J, Molyneaux PL, Li Q, Villalba JA, Tzouvelekis A, Lynn H, Juan-Guardela BM, Risquez C, Osorio JC, Yan X, Michel G, Aurelien N, Lindell KO, Klesen MJ, Moffatt MF, Cookson WO, Zhang Y, Garcia JGN, Noth I, Prasse A, Bar-Joseph Z, Gibson KF, Zhao H, Herzog EL, Rosas IO, Maher TM, Kaminski N. PMID: 28942086; PMCID: PMC5677538.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    232. Time for an International Consensus on Hypersensitivity Pneumonitis. A Call to Arms. Am J Respir Crit Care Med. 2017 09 15; 196(6):665-666. Molyneaux PL, Maher TM. PMID: 28723313.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    233. Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries. BMC Pulm Med. 2017 Sep 15; 17(1):124. Maher TM, Molina-Molina M, Russell AM, Bonella F, Jouneau S, Ripamonti E, Axmann J, Vancheri C. PMID: 28915874; PMCID: PMC5602932.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    234. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. Lancet Respir Med. 2017 10; 5(10):806-815. Birring SS, Wijsenbeek MS, Agrawal S, van den Berg JWK, Stone H, Maher TM, Tutuncu A, Morice AH. PMID: 28923239.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    235. Validity, responsiveness and minimum clinically important difference of the incremental shuttle walk in idiopathic pulmonary fibrosis: a prospective study. Thorax. 2017 Sep 07. Nolan CM, Delogu V, Maddocks M, Patel S, Barker RE, Jones SE, Kon SSC, Maher TM, Cullinan P, Man WD. PMID: 28883090.
      View in: PubMed   Mentions: 17     Fields:    
    236. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. Eur Respir J. 2017 08; 50(2). Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A, IPF Project Consortium. PMID: 28860269.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    237. Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017 08 15; 196(4):479-493. Barratt SL, Blythe T, Jarrett C, Ourradi K, Shelley-Fraser G, Day MJ, Qiu Y, Harper S, Maher TM, Oltean S, Hames TJ, Scotton CJ, Welsh GI, Bates DO, Millar AB. PMID: 28661183; PMCID: PMC5564672.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimals
    238. The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis. Oncotarget. 2017 Jul 25; 8(30):48737-48754. Conforti F, Davies ER, Calderwood CJ, Thatcher TH, Jones MG, Smart DE, Mahajan S, Alzetani A, Havelock T, Maher TM, Molyneaux PL, Thorley AJ, Tetley TD, Warner JA, Packham G, Ganesan A, Skipp PJ, Marshall BJ, Richeldi L, Sime PJ, O'Reilly KMA, Davies DE. PMID: 28467787; PMCID: PMC5564721.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    239. Home spirometry for idiopathic pulmonary fibrosis: ready for prime time? Eur Respir J. 2017 07; 50(1). Maher TM. PMID: 28729480.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    240. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis. Arthritis Rheumatol. 2017 08; 69(8):1670-1678. Goh NS, Hoyles RK, Denton CP, Hansell DM, Renzoni EA, Maher TM, Nicholson AG, Wells AU. PMID: 28426895.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    241. Update in Interstitial Lung Disease 2016. Am J Respir Crit Care Med. 2017 07 15; 196(2):132-138. Wells AU, Maher TM. PMID: 28530124; PMCID: PMC5519972.
      View in: PubMed   Mentions: 3     Fields:    
    242. Coconut oil has less satiating properties than medium chain triglyceride oil. Physiol Behav. 2017 Oct 01; 179:422-426. Kinsella R, Maher T, Clegg ME. PMID: 28689741.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    243. Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis. Eur Respir J. 2017 07; 50(1). Jacob J, Bartholmai BJ, Rajagopalan S, Kokosi M, Maher TM, Nair A, Karwoski R, Renzoni E, Walsh SLF, Hansell DM, Wells AU. PMID: 28679612.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    244. Cough in fibrotic lung disease: An unresolved challenge. Respirology. 2017 11; 22(8):1491-1492. Saunders P, Maher TM. PMID: 28677213.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    245. Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):75-81. Distler O, Brown KK, Distler JHW, Assassi S, Maher TM, Cottin V, Varga J, Coeck C, Gahlemann M, Sauter W, Schmidt H, Highland KB, SENSCIS™ trial investigators. PMID: 28664834.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    246. Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017 06 15; 195(12):1640-1650. Molyneaux PL, Willis-Owen SAG, Cox MJ, James P, Cowman S, Loebinger M, Blanchard A, Edwards LM, Stock C, Daccord C, Renzoni EA, Wells AU, Moffatt MF, Cookson WOC, Maher TM. PMID: 28085486; PMCID: PMC5476909.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansCells
    247. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Trials. 2017 06 15; 18(1):275. Saunders P, Tsipouri V, Keir GJ, Ashby D, Flather MD, Parfrey H, Babalis D, Renzoni EA, Denton CP, Wells AU, Maher TM. PMID: 28619061; PMCID: PMC5471887.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    248. Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial. Trials. 2017 04 28; 18(1):201. Visca D, Tsipouri V, Mori L, Firouzi A, Fleming S, Farquhar M, Leung E, Maher TM, Cullinan P, Hopkinson N, Wells AU, Banya W, Whitty JA, Adamali H, Spencer LG, Sestini P, Renzoni EA. PMID: 28454553; PMCID: PMC5410093.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    249. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone. Respiration. 2017; 93(6):415-423. Kreuter M, Spagnolo P, Wuyts W, Renzoni E, Koschel D, Bonella F, Maher TM, Kolb M, Weycker D, Kirchgässler KU, Costabel U. PMID: 28399537; PMCID: PMC5452370.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    250. Clinical trial research in focus: why do so many clinical trials fail in IPF? Lancet Respir Med. 2017 05; 5(5):372-374. Spagnolo P, Maher TM. PMID: 28412184.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    251. A lesson in plasticity: a 74-year-old man with plastic bronchitis. Thorax. 2017 11; 72(11):1055-1057. Shah A, Donovan J, Marino P, Shah PL, Devaraj A, Wechalekar K, Maher TM, Loebinger MR, Wilson R. PMID: 28373346.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    252. A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK. Pharmacoeconomics. 2017 04; 35(4):479-491. Rinciog C, Watkins M, Chang S, Maher TM, LeReun C, Esser D, Diamantopoulos A. PMID: 28039616; PMCID: PMC5357477.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    253. Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis. J Manag Care Spec Pharm. 2017 Mar; 23(3-b Suppl):S17-S24. Fisher M, Nathan SD, Hill C, Marshall J, Dejonckheere F, Thuresson PO, Maher TM. PMID: 28287347; PMCID: PMC10408422.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCTClinical Trials
    254. Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension. J Manag Care Spec Pharm. 2017 Mar; 23(3-b Suppl):S3-S4. Maher TM, Dejonckheere F, Nathan SD. PMID: 28287348; PMCID: PMC10408404.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    255. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis. Respir Res. 2017 02 01; 18(1):29. Molyneaux PL, Cox MJ, Wells AU, Kim HC, Ji W, Cookson WO, Moffatt MF, Kim DS, Maher TM. PMID: 28143484; PMCID: PMC5286769.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCells
    256. Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis. Thorax. 2017 02; 72(2):137-147. Alton EW, Beekman JM, Boyd AC, Brand J, Carlon MS, Connolly MM, Chan M, Conlon S, Davidson HE, Davies JC, Davies LA, Dekkers JF, Doherty A, Gea-Sorli S, Gill DR, Griesenbach U, Hasegawa M, Higgins TE, Hironaka T, Hyndman L, McLachlan G, Inoue M, Hyde SC, Innes JA, Maher TM, Moran C, Meng C, Paul-Smith MC, Pringle IA, Pytel KM, Rodriguez-Martinez A, Schmidt AC, Stevenson BJ, Sumner-Jones SG, Toshner R, Tsugumine S, Wasowicz MW, Zhu J. PMID: 27852956; PMCID: PMC5284333.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansAnimalsCells
    257. Blood-based Diagnosis of Idiopathic Pulmonary Fibrosis. Fantasy or Reality? Am J Respir Crit Care Med. 2016 11 15; 194(10):1182-1184. Maher TM. PMID: 27845590.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    258. Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns. Eur Respir J. 2016 11; 48(5):1524-1526. Kreuter M, Wijsenbeek MS, Vasakova M, Spagnolo P, Kolb M, Costabel U, Weycker D, Kirchgaessler KU, Maher TM. PMID: 27799399.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    259. Reply: Daily Home Spirometry: A New Milestone in the Field of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016 10 15; 194(8):1034-1035. Russell AM, Maher TM, all authors. PMID: 27739889.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    260. Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016 10 15; 194(8):989-997. Russell AM, Adamali H, Molyneaux PL, Lukey PT, Marshall RP, Renzoni EA, Wells AU, Maher TM. PMID: 27089018; PMCID: PMC5067818.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    261. Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted. Respir Med. 2016 11; 120:131-133. Ward K, Spurr L, Goldman NR, Margaritopoulos GA, Kokosi M, Renzoni E, Chua F, Maher TM, Ward S, Wells AU. PMID: 27817810.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    262. Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis. Thorax. 2017 02; 72(2):148-153. Kreuter M, Bonella F, Maher TM, Costabel U, Spagnolo P, Weycker D, Kirchgaessler KU, Kolb M. PMID: 27708114; PMCID: PMC5284334.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    263. Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume. Thorax. 2017 Apr; 72(4):340-346. Kolb M, Richeldi L, Behr J, Maher TM, Tang W, Stowasser S, Hallmann C, du Bois RM. PMID: 27672117; PMCID: PMC5520269.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCTClinical Trials
    264. Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' reply. Lancet Respir Med. 2016 09; 4(9):e48. Kreuter M, Wuyts W, Renzoni E, Koschel D, Maher TM, Kolb M, Weycker D, Spagnolo P, Kirchgaessler KU, Herth FJF, Costabel U. PMID: 27599251.
      View in: PubMed   Mentions: 3     Fields:    
    265. Precision medicine in idiopathic pulmonary fibrosis. QJM. 2016 Sep; 109(9):585-587. Maher TM. PMID: 27512106; PMCID: PMC5943832.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    266. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016 08 01; 194(3):265-75. Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, Behr J, Brown KK, Cottin V, Flaherty KR, Fukuoka J, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kolb M, Lynch DA, Myers JL, Raghu G, Richeldi L, Taniguchi H, Martinez FJ. PMID: 27299520.
      View in: PubMed   Mentions: 533     Fields:    Translation:Humans
    267. Medicine and Me: a breath of fresh air for IPF. Lancet Respir Med. 2016 08; 4(8):615-616. Maher T. PMID: 27511633.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    268. Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia. BMC Genet. 2016 06 07; 17(1):74. Fingerlin TE, Zhang W, Yang IV, Ainsworth HC, Russell PH, Blumhagen RZ, Schwarz MI, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch DA, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Murphy E, Smith K, McKean D, Pedersen BS, Talbert J, Powers J, Markin CR, Beckman KB, Lathrop M, Freed B, Langefeld CD, Schwartz DA. PMID: 27266705; PMCID: PMC4895966.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    269. Recent advances in understanding idiopathic pulmonary fibrosis. F1000Res. 2016; 5. Daccord C, Maher TM. PMID: 27303645; PMCID: PMC4890320.
      View in: PubMed   Mentions: 35     Fields:    
    270. Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis. Eur Respir J. 2016 06; 47(6):1776-84. Kreuter M, Wijsenbeek MS, Vasakova M, Spagnolo P, Kolb M, Costabel U, Weycker D, Kirchgaessler KU, Maher TM. PMID: 27103382.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    271. Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. Thorax. 2016 08; 71(8):701-11. Mercer PF, Woodcock HV, Eley JD, Platé M, Sulikowski MG, Durrenberger PF, Franklin L, Nanthakumar CB, Man Y, Genovese F, McAnulty RJ, Yang S, Maher TM, Nicholson AG, Blanchard AD, Marshall RP, Lukey PT, Chambers RC. PMID: 27103349; PMCID: PMC4975851.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCells
    272. Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. Lancet Respir Med. 2016 05; 4(5):381-9. Kreuter M, Wuyts W, Renzoni E, Koschel D, Maher TM, Kolb M, Weycker D, Spagnolo P, Kirchgaessler KU, Herth FJ, Costabel U. PMID: 27050871.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    273. Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease? Trends Mol Med. 2016 Apr; 22(4):303-316. Byrne AJ, Maher TM, Lloyd CM. PMID: 26979628.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansAnimalsCells
    274. Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis. Clin Sci (Lond). 2016 Apr; 130(8):575-86. Evans IC, Barnes JL, Garner IM, Pearce DR, Maher TM, Shiwen X, Renzoni EA, Wells AU, Denton CP, Laurent GJ, Abraham DJ, McAnulty RJ. PMID: 26744410; PMCID: PMC4782165.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    275. Aerobic Glycolysis and the Warburg Effect. An Unexplored Realm in the Search for Fibrosis Therapies? Am J Respir Crit Care Med. 2015 Dec 15; 192(12):1407-9. Maher TM. PMID: 26669469; PMCID: PMC4731726.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    276. Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives. Biomed Res Int. 2015; 2015:329481. Kreuter M, Bonella F, Wijsenbeek M, Maher TM, Spagnolo P. PMID: 26779535; PMCID: PMC4686637.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    277. Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique. Adv Ther. 2015 Oct; 32(10):929-43. Maher TM, Whyte MK, Hoyles RK, Parfrey H, Ochiai Y, Mathieson N, Turnbull A, Williamson N, Bennett BM. PMID: 26498943; PMCID: PMC4635174.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    278. Improved correction for the tissue fraction effect in lung PET/CT imaging. Phys Med Biol. 2015 Sep 21; 60(18):7387-402. Holman BF, Cuplov V, Millner L, Hutton BF, Maher TM, Groves AM, Thielemans K. PMID: 26350580.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    279. Personalized medicine in idiopathic pulmonary fibrosis: facts and promises. Curr Opin Pulm Med. 2015 Sep; 21(5):470-8. Spagnolo P, Tzouvelekis A, Maher TM. PMID: 26132817.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    280. New guideline on treatment of idiopathic pulmonary fibrosis. Lancet Respir Med. 2015 Sep; 3(9):e31-e32. Spagnolo P, Bonella F, Maher TM. PMID: 26380887.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    281. Challenges in the classification of fibrotic ILD. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 03; 32 Suppl 1:4-9. Bendstrup E, Maher TM, Manali ED, Wijsenbeek M. PMID: 26237436.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    282. Nintedanib in idiopathic pulmonary fibrosis. Drugs Today (Barc). 2015 Jun; 51(6):345-56. Woodcock HV, Maher TM. PMID: 26261848.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    283. Transcriptional phenotyping of fibrotic lung disease: a new gold standard? Lancet Respir Med. 2015 Jun; 3(6):423-4. Maher TM. PMID: 26003388.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    284. Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy. Pharmacol Ther. 2015 Aug; 152:18-27. Spagnolo P, Maher TM, Richeldi L. PMID: 25946646.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimals
    285. Rasch analysis and impact factor methods both yield valid and comparable measures of health status in interstitial lung disease. J Clin Epidemiol. 2015 Sep; 68(9):1019-27. Patel AS, Siegert RJ, Bajwah S, Brignall K, Gosker HR, Moxham J, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS. PMID: 26004514.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    286. Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung disease. Respirology. 2015 Jul; 20(5):834-45. Maher TM, Piper A, Song Y, Restrepo MI, Eves ND. PMID: 25824415.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    287. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study. Lancet Respir Med. 2015 Jun; 3(6):462-72. Jenkins RG, Simpson JK, Saini G, Bentley JH, Russell AM, Braybrooke R, Molyneaux PL, McKeever TM, Wells AU, Flynn A, Hubbard RB, Leeming DJ, Marshall RP, Karsdal MA, Lukey PT, Maher TM. PMID: 25770676.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    288. Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis. Eur Respir Rev. 2015 Mar; 24(135):58-64. Cottin V, Maher T. PMID: 25726556; PMCID: PMC9487763.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    289. Combination therapy: the future of management for idiopathic pulmonary fibrosis? Lancet Respir Med. 2014 Nov; 2(11):933-942. Wuyts WA, Antoniou KM, Borensztajn K, Costabel U, Cottin V, Crestani B, Grutters JC, Maher TM, Poletti V, Richeldi L, Vancheri C, Wells AU. PMID: 25439569.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    290. Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better? Respirology. 2014 Nov; 19(8):1095-6. Russell AM, Maher TM. PMID: 25302755.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    291. UK trainee experience in interstitial lung disease: results from a British Thoracic Society survey. Thorax. 2015 Feb; 70(2):183. Sharp C, Maher TM, Welham S, Gibbons M. PMID: 25352531.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    292. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2014 Oct 15; 190(8):906-13. Molyneaux PL, Cox MJ, Willis-Owen SA, Mallia P, Russell KE, Russell AM, Murphy E, Johnston SL, Schwartz DA, Wells AU, Cookson WO, Maher TM, Moffatt MF. PMID: 25184687; PMCID: PMC4299577.
      View in: PubMed   Mentions: 247     Fields:    Translation:HumansCells
    293. Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2014 Jul 15; 190(2):208-17. Corte TJ, Keir GJ, Dimopoulos K, Howard L, Corris PA, Parfitt L, Foley C, Yanez-Lopez M, Babalis D, Marino P, Maher TM, Renzoni EA, Spencer L, Elliot CA, Birring SS, O'Reilly K, Gatzoulis MA, Wells AU, Wort SJ, BPHIT Study Group. PMID: 24937643; PMCID: PMC4226056.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    294. Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Jul 08; 31(2):82-90. Keir GJ, Walsh SL, Gatzoulis MA, Marino PS, Dimopoulos K, Alonso R, Raposeiras-Roubin S, Renzoni EA, Maher TM, Wells AU, Wort SJ. PMID: 25078636.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    295. Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era? Eur Respir J. 2014 May; 43(5):1233-6. Maher TM. PMID: 24789946.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    296. Respiratory microbiome in IPF: cause, effect, or biomarker? Lancet Respir Med. 2014 Jul; 2(7):511-3. Molyneaux PL, Maher TM. PMID: 24767768.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    297. Immunosuppression for connective tissue disease-related pulmonary disease. Semin Respir Crit Care Med. 2014 Apr; 35(2):265-73. Maher TM. PMID: 24668541.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    298. Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events. Adv Ther. 2014 Apr; 31(4):375-91. Costabel U, Bendstrup E, Cottin V, Dewint P, Egan JJ, Ferguson J, Groves R, Hellström PM, Kreuter M, Maher TM, Molina-Molina M, Nordlind K, Sarafidis A, Vancheri C. PMID: 24639005; PMCID: PMC4003341.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    299. The treatment of idiopathic pulmonary fibrosis. F1000Prime Rep. 2014; 6:16. Woodcock HV, Maher TM. PMID: 24669297; PMCID: PMC3944742.
      View in: PubMed   Mentions: 27  
    300. Case-based discussion from the Royal Devon and Exeter NHS Foundation Trust: a painful paradox. Thorax. 2014 Aug; 69(8):779-81. Sharp C, Powari M, Mascarenhas R, Spiers A, Froeschle PO, Patel BD, Silver DA, Maher TM, Gibbons MA. PMID: 24584169.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    301. Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology. Respirology. 2014 Apr; 19(3):428-37. Piper A, Song Y, Eves ND, Maher TM. PMID: 24708032; PMCID: PMC7169150.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    302. Pulmonary Langerhans cell histiocytosis (PLCH): a new UK register. Thorax. 2014 Aug; 69(8):766-7. Mason RH, Foley NM, Branley HM, Adamali HI, Hetzel M, Maher TM, Suntharalingam J. PMID: 24482091.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    303. An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. Lancet Respir Med. 2014 Feb; 2(2):123-30. Walsh SL, Wells AU, Sverzellati N, Keir GJ, Calandriello L, Antoniou KM, Copley SJ, Devaraj A, Maher TM, Renzoni E, Nicholson AG, Hansell DM. PMID: 24503267.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    304. Rituximab in severe, treatment-refractory interstitial lung disease. Respirology. 2014 Apr; 19(3):353-9. Keir GJ, Maher TM, Ming D, Abdullah R, de Lauretis A, Wickremasinghe M, Nicholson AG, Hansell DM, Wells AU, Renzoni EA. PMID: 24286447.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    305. Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease. J Immunol. 2013 Nov 01; 191(9):4867-79. Datta A, Alexander R, Sulikowski MG, Nicholson AG, Maher TM, Scotton CJ, Chambers RC. PMID: 24081992; PMCID: PMC3836180.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    306. Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis. Thorax. 2014 Mar; 69(3):287-8. Keir GJ, Garfield B, Hansell DM, Loebinger MR, Wilson R, Renzoni EA, Wells AU, Maher TM. PMID: 24029745.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    307. Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine. Curr Opin Pulm Med. 2013 Sep; 19(5):460-5. Maher TM. PMID: 23912190.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    308. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis. Eur Respir Rev. 2013 Sep 01; 22(129):376-81. Molyneaux PL, Maher TM. PMID: 23997064; PMCID: PMC9487348.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansAnimals
    309. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients. Eur J Nucl Med Mol Imaging. 2014 Feb; 41(2):337-42. Win T, Thomas BA, Lambrou T, Hutton BF, Screaton NJ, Porter JC, Maher TM, Endozo R, Shortman RI, Afaq A, Lukey P, Ell PJ, Groves AM. PMID: 23942907; PMCID: PMC3890564.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    310. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. Respir Res. 2013 Aug 02; 14:80. Lindahl GE, Stock CJ, Shi-Wen X, Leoni P, Sestini P, Howat SL, Bou-Gharios G, Nicholson AG, Denton CP, Grutters JC, Maher TM, Wells AU, Abraham DJ, Renzoni EA. PMID: 23915349; PMCID: PMC3750263.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    311. The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease. Respir Med. 2013 Sep; 107(9):1438-43. Patel AS, Siegert RJ, Keir GJ, Bajwah S, Barker RD, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS. PMID: 23867809.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    312. Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib. Drug Des Devel Ther. 2013; 7:503-10. Woodcock HV, Molyneaux PL, Maher TM. PMID: 23818761; PMCID: PMC3693725.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    313. PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery. Eur Respir Rev. 2013 Jun 01; 22(128):148-52. Maher TM. PMID: 23728868; PMCID: PMC9487381.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    314. Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: one step at a time. Am J Respir Crit Care Med. 2013 Jun 01; 187(11):1271-2. Spagnolo P, Luppi F, Maher TM, Wuyts WA, Grutters JC. PMID: 23725621.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    315. Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis. Eur Respir J. 2013 Jul; 42(1):230-8. Richeldi L, Collard HR, du Bois RM, Jenkins G, Kolb M, Maher TM, Raghu G, Vancheri C, Laurent GJ. PMID: 23682111.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    316. Provision of home mechanical ventilation and sleep services for England survey. Thorax. 2013 Sep; 68(9):880-1. Mandal S, Suh E, Davies M, Smith I, Maher TM, Elliott MW, Davidson AC, Hart N. PMID: 23604459.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    317. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet. 2013 Jun; 45(6):613-20. Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch D, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Cogan JD, Mason WR, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Smith K, McKean D, Pedersen BS, Talbert J, Kidd RN, Markin CR, Beckman KB, Lathrop M, Schwarz MI, Schwartz DA. PMID: 23583980; PMCID: PMC3677861.
      View in: PubMed   Mentions: 411     Fields:    Translation:HumansCells
    318. Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology. Respirology. 2013 Apr; 18(3):555-64. Eves ND, Song Y, Piper A, Maher TM. PMID: 23336426.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    319. Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment. Thorax. 2013 Aug; 68(8):780-1. Lota HK, Keir GJ, Hansell DM, Nicholson AG, Maher TM, Wells AU, Renzoni EA. PMID: 23515438.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    320. Exercise-induced haemoptysis: a thoroughbred cause? Thorax. 2013 Jun; 68(6):599-600. Hull JH, Menzies-Gow A, Nicholson AG, Mohiaddin RH, Maher TM. PMID: 23404840.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    321. Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis. J Rheumatol. 2013 Apr; 40(4):435-46. De Lauretis A, Sestini P, Pantelidis P, Hoyles R, Hansell DM, Goh NS, Zappala CJ, Visca D, Maher TM, Denton CP, Ong VH, Abraham DJ, Kelleher P, Hector L, Wells AU, Renzoni EA. PMID: 23378460.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    322. Obliterative bronchiolitis in fibreglass workers: a new occupational disease? Occup Environ Med. 2013 May; 70(5):357-9. Cullinan P, McGavin CR, Kreiss K, Nicholson AG, Maher TM, Howell T, Banks J, Newman Taylor AJ, Chen CH, Tsai PJ, Shih TS, Burge PS. PMID: 23322914.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    323. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax. 2013 May; 68(5):436-41. Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, Russell AM, Denton CP, Abraham DJ, Hansell DM, Nicholson AG, Maher TM, Wells AU, Lindahl GE, Renzoni EA. PMID: 23321605.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    324. Successful treatment of progressive diffuse PEComatosis. Eur Respir J. 2012 Dec; 40(6):1578-80. Lawson K, Maher TM, Hansell DM, Nicholson AG. PMID: 23204027.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    325. The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status. Thorax. 2013 Jan; 68(1):57-65. Patel AS, Siegert RJ, Creamer D, Larkin G, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS. PMID: 23065052.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    326. Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts. Adv Biosci Biotechnol. 2012 Oct; 3(6A):657-664. Sisson TH, Maher TM, Ajayi IO, King JE, Higgins PD, Booth AJ, Sagana RL, Huang SK, White ES, Moore BB, Horowitz JC. PMID: 23355956; PMCID: PMC3553664.
      View in: PubMed   Mentions: 43  
    327. A clinical approach to diffuse parenchymal lung disease. Immunol Allergy Clin North Am. 2012 Nov; 32(4):453-72. Maher TM. PMID: 23102061.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    328. Current and novel drug therapies for idiopathic pulmonary fibrosis. Drug Des Devel Ther. 2012; 6:261-72. Adamali HI, Maher TM. PMID: 23055696; PMCID: PMC3463380.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    329. Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis. Respirology. 2012 Jul; 17(5):861-8. Amar RK, Jick SS, Rosenberg D, Maher TM, Meier CR. PMID: 22563933.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    330. Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008. Respiration. 2012; 84(3):200-6. Amar RK, Jick SS, Rosenberg D, Maher TM, Meier CR. PMID: 22678015.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    331. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012 Sep; 67(9):804-10. Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS. PMID: 22555278.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    332. Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumonia. Respirology. 2012 May; 17(4):674-80. Corte TJ, Wort SJ, MacDonald PS, Edey A, Hansell DM, Renzoni E, Maher TM, Nicholson AG, Bandula S, Bresser P, Wells AU. PMID: 22212399.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    333. Year in review 2011: acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer. Respirology. 2012 Apr; 17(3):554-62. Takahashi K, Eves ND, Piper A, Song Y, Maher TM. PMID: 22248252.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    334. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012 Aug; 40(2):377-85. Reddy TL, Tominaga M, Hansell DM, von der Thusen J, Rassl D, Parfrey H, Guy S, Twentyman O, Rice A, Maher TM, Renzoni EA, Wells AU, Nicholson AG. PMID: 22441748.
      View in: PubMed   Mentions: 122     Fields:    Translation:Humans
    335. Elevated nocturnal desaturation index predicts mortality in interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar; 29(1):41-50. Corte TJ, Wort SJ, Talbot S, Macdonald PM, Hansel DM, Polkey M, Renzoni E, Maher TM, Nicholson AG, Wells AU. PMID: 23311122.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    336. Diffuse cystic lung disease of unexplained cause with coexistent small airway disease: a possible causal relationship? Am J Surg Pathol. 2012 Feb; 36(2):228-34. Rowan C, Hansell DM, Renzoni E, Maher TM, Wells AU, Polkey MI, Rehal PK, Ibrahim WH, Kwong GN, Colby TV, Pistolesi M, Bigazzi F, Comin CE, Nicholson AG. PMID: 22082605.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    337. Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy. Eur Respir J. 2012 Sep; 40(3):641-8. Keir GJ, Maher TM, Hansell DM, Denton CP, Ong VH, Singh S, Wells AU, Renzoni EA. PMID: 22282550.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    338. Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment. Clin Chest Med. 2012 Mar; 33(1):69-83. Maher TM. PMID: 22365247.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    339. 18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials. Eur J Nucl Med Mol Imaging. 2012 Mar; 39(3):521-8. Win T, Lambrou T, Hutton BF, Kayani I, Screaton NJ, Porter JC, Maher TM, Endozo R, Shortman RI, Lukey P, Groves AM. PMID: 22258710.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    340. Ambulatory oxygen in interstitial lung disease. Eur Respir J. 2011 Oct; 38(4):987-90. Visca D, Montgomery A, de Lauretis A, Sestini P, Soteriou H, Maher TM, Wells AU, Renzoni EA. PMID: 21965506.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    341. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J. 2012 Mar; 39(3):661-8. Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG, Colby TV, Renzoni E, Maher TM, Wells AU. PMID: 21920896.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    342. In search of the fibrotic epithelial cell: opportunities for a collaborative network. Thorax. 2012 Feb; 67(2):179-82. Jenkins G, Blanchard A, Borok Z, Bradding P, Ehrhardt C, Fisher A, Hirani N, Johnson S, Königshoff M, Maher TM, Millar A, Parfrey H, Scotton C, Tetley T, Thickett D, Wolters P, ECIPF workshop. PMID: 21680569.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    343. Idiopathic pulmonary fibrosis-related pulmonary hypertension; an exercising diagnosis? Respirology. 2011 Apr; 16(3):381-3. Maher TM, Wells AU. PMID: 21299689.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    344. Year in review 2010: interstitial lung diseases, acute lung injury, sleep, physiology, imaging, bronchoscopic intervention and lung cancer. Respirology. 2011 Apr; 16(3):553-63. Eastwood PR, Takahashi K, Lee P, Maher TM. PMID: 21244574.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    345. If it was good enough for Aristotle...... Thorax. 2011 Mar; 66(3):183-84. Maher TM, Wells AU. PMID: 21233482.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    346. Sildenafil in idiopathic pulmonary fibrosis. N Engl J Med. 2010 11 25; 363(22):2169; author reply 2170-1. Maher TM. PMID: 21105804.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    347. Pirfenidone in idiopathic pulmonary fibrosis. Drugs Today (Barc). 2010 Jul; 46(7):473-82. Maher TM. PMID: 20683502.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    348. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010 Jul 01; 182(1):73-82. Maher TM, Evans IC, Bottoms SE, Mercer PF, Thorley AJ, Nicholson AG, Laurent GJ, Tetley TD, Chambers RC, McAnulty RJ. PMID: 20203246; PMCID: PMC2902759.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCells
    349. Year in review 2009: Interstitial lung diseases, acute injury, sleep, physiology, imaging and bronchoscopic intervention. Respirology. 2010 Jan; 15(1):172-81. Eastwood PR, Maher TM, Wells AU, Lam B. PMID: 20199638.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    350. Pulmonary fibrosis associated with psychotropic drug therapy: a case report. J Med Case Rep. 2009 Nov 16; 3:126. Thornton C, Maher TM, Hansell D, Nicholson AG, Wells AU. PMID: 20062766; PMCID: PMC2803800.
      View in: PubMed   Mentions: 7     Fields:    
    351. Lost in translation; from animal models of pulmonary fibrosis to human disease. Respirology. 2009 Sep; 14(7):915-6. Maher TM, Wells AU. PMID: 19740253.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    352. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest. 2009 Sep; 119(9):2550-63. Scotton CJ, Krupiczojc MA, Königshoff M, Mercer PF, Lee YC, Kaminski N, Morser J, Post JM, Maher TM, Nicholson AG, Moffatt JD, Laurent GJ, Derian CK, Eickelberg O, Chambers RC. PMID: 19652365; PMCID: PMC2735922.
      View in: PubMed   Mentions: 145     Fields:    Translation:HumansAnimalsCells
    353. Understanding nonspecific interstitial pneumonia: the need for a diagnostic gold standard. Am J Respir Crit Care Med. 2009 Feb 01; 179(3):255-6; author reply 256. Maher TM. PMID: 19158329.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    354. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am J Pathol. 2009 Apr; 174(4):1264-79. Xu MY, Porte J, Knox AJ, Weinreb PH, Maher TM, Violette SM, McAnulty RJ, Sheppard D, Jenkins G. PMID: 19147812; PMCID: PMC2671359.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansAnimalsCells
    355. Optimal treatment for idiopathic pulmonary fibrosis. Thorax. 2008 Dec; 63(12):1120-1; author reply 1121. Maher TM, Wells AU. PMID: 19020278.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    356. The diagnosis of idiopathic pulmonary fibrosis and its complications. Expert Opin Med Diagn. 2008 Dec; 2(12):1317-31. Maher TM. PMID: 23496780.
      View in: PubMed   Mentions: 1     Fields:    
    357. Vibration response imaging technology in healthy subjects. AJR Am J Roentgenol. 2008 Sep; 191(3):845-52. Yigla M, Gat M, Meyer JJ, Friedman PJ, Maher TM, Madison JM. PMID: 18716118.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    358. Native valve Aspergillus endocarditis complicating lung transplantation. J Heart Lung Transplant. 2008 Aug; 27(8):910-3. Maher TM, Carby MR, Hall AV, Banner NR, Burke MM, Dreyfus GD. PMID: 18656806.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    359. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008 Jun 01; 177(11):1248-54. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU. PMID: 18369202.
      View in: PubMed   Mentions: 363     Fields:    Translation:Humans
    360. Reproducibility of dynamically represented acoustic lung images from healthy individuals. Thorax. 2008 Jun; 63(6):542-8. Maher TM, Gat M, Allen D, Devaraj A, Wells AU, Geddes DM. PMID: 18024534; PMCID: PMC2571960.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    361. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J. 2007 Nov; 30(5):835-9. Maher TM, Wells AU, Laurent GJ. PMID: 17978154.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansAnimals
    362. CT findings of varicella pneumonia after lung transplantation. AJR Am J Roentgenol. 2007 Jun; 188(6):W557-9. Maher TM, Gupta NK, Burke MM, Carby MR. PMID: 17515348.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    363. Acute breathlessness. Br J Hosp Med (Lond). 2007 Mar; 68(3):M40-3. Maher TM, Wells AU. PMID: 17419463.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    364. Highly polymorphic short tandem repeat analyses clarify complex molecular test results. Diagn Mol Pathol. 2001 Sep; 10(3):179-89. Lebo RV, Maher T, Farrer L, Fenerci EY, Milunsky JM. PMID: 11552721.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    365. Substituting lifestyle management for pharmacological control of blood pressure: a pilot study in Australian general practice. Blood Press. 2000; 9(5):267-74. Reid CM, Maher T, Jennings GL, Heart Project Steering Committee. PMID: 11193130.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    366. Vascular density does not predict future metastatic disease in clinical stage 1 non-seminomatous germ cell tumours of the testis. Histopathology. 1998 Mar; 32(3):217-24. Maher TM, Lee AH. PMID: 9568506.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    367. Afferent input from peripheral chemoreceptors in response to hypoxia and amino acid neurotransmitter generation in the medulla. Adv Exp Med Biol. 1996; 410:365-9. Kazemi H, Beagle J, Maher T, Hoop B. PMID: 9030326.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    368. Distressful events in the ICU as perceived by patients recovering from coronary artery bypass surgery. Heart Lung. 1994 Jul-Aug; 23(4):323-7. Pennock BE, Crawshaw L, Maher T, Price T, Kaplan PD. PMID: 7960858.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    369. Phase II study of merbarone (NSC 336628) in patients with advanced gastric carcinoma. Cancer Invest. 1994; 12(5):488-90. Ajani JA, Winn R, Baez L, Pollock T, Maher T, Hallinan-Fueger B, Newman J. PMID: 7922705.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    370. Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group B. J Natl Cancer Inst. 1993 Feb 17; 85(4):316-20. Clamon G, Herndon J, Perry MC, Ozer H, Kreisman H, Maher T, Ellerton J, Green MR. PMID: 8381188.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    371. Surgical therapy for left ventricular aneurysms. A ten-year experience. Circulation. 1989 Jun; 79(6 Pt 2):I102-7. Magovern GJ, Sakert T, Simpson K, Laub GW, Park SB, Liebler G, Burkholder J, Maher T, Benckart D, Magovern GJ. PMID: 2720938.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Toby's Networks
    Concepts (749)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.